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1Abstract
The capacities of glucose transport and the intracellular
phosphoribosylpyrophosphate (PRPP) concentrations of Ehrlich
ascites tumour (EAT) cells are inversely correlated under certain
conditions. The inverse relationship holds when the tumour
develops in vivo wh-en the tumour bearing mice are treated with
diabetogenic agents, such as alloxan and streptozotocin or when
the cells are incubated with various concentrations of glucose in
vitro. The metabolic inhibitor, 2,4-dinitrophenol increases the
number of glucose carriers on the plasma membrane and decreases
the intracellular PREP of EAT cells in vitro whereas methylene
blue, an electron acce-ptor, cannot affect both of them. Addition
of methotrexate (MTX) Induces accumulation of intracellular PRPP
and meanwhile, suppresses the glucose transport activity in EAT
cells in vitro. Hypoxanthine prevents the accumulation of PRPP
in MTX-treated cells and restores the glucose transport activity
to normal.
The inverse relationship can no longer hold when EAT cells
were treated with recombinant human tumour necrosis factor
(rhTNF) or hyperthermia at 430C. rhTNF suppresses glucose
transport activity without exerting significant effect on the
level of intracellular PRPP in EAT cells. Hyperthermic
treatment reduces the rate of glucose uptake and the numbers of
glucose carriers of EAT cells with different extents whereas no
significant change in PRPP level can be observed under this
treatment.
2In vitro studies in the combined effect of hyperthermia
and anti-cancer agents on EAT cells reveal that the anti-growth
effect of hyperthermia on EAT cells can be amplified by MTX, 5-
fluorouracil, cytarabine, tumour necrosis factor containing mouse
serum and rhTNF. Furthermore, the suppression of glucose
transport induced by hyperthermic treatment can be enhanced when
combined with MTX or rhTNF. The degree of enhancement is
dependent on the schedule of treatments. Cells pretreated with
MTX or rhTNF prior to heat gives a higher rate of suppression in
glucose transport than cells co-treated with these agents during
the course of hyperthermia.
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AN OVERVIEW
Use of Ehrlich Aacites Tumour Cells as Experimental Tumour model
I n the present study, the tumour model employed is Ehrlich
ascites tumour cells. The origin of Ehrlich ascites tumour Is a
solid line of Ehrlich carcinoma, an epithelial mammary carcinoma
of mice. It was first converted into ascitic form by Lowenthal
in 1932 and carried in outbred mice by serial intraperitoneal
passage. The subline of Ehrlich ascites tumour we used is Ny
Klein which was converted from solid Ehrlich carcinoma by K1-ein
and Klein (1956) into the ascitic form and used as the tetraplold
Ehrlich ascites tumour.
Ehrlich ascites tumour is an ideal experimental model in
the study of regulation of glucose transport, since it is easy to
handle and can grow very rapidly either in vivo or in vitro.
Carrier Mediated Glucose Transport in Mammalian cells
Most if not all the mammalian cells contain a plasma
membrane protein involved in transporting glucose into the cell
(Elbrlnk and Bihler, 1975). The nature of glucose carrier of
human erythrocytes has been much extensively studied. This
transport element is a glycoprotein with the apparent molecular
weight estimated by sodium dodecyl sulfate polyacrylamide gel
electrophoresis of about 55,000. After the removal of the
2carbohydrate moiety, its molecular weight is about 46,000(
Kasahara and Hinkle, 1977 Cuppoletti and Jung, 1981). The
glucose carrier is found to be stereospecific that it cannot bind
L-glucose( Zoccli et al., 1978). Recently, the amino acid
sequence of glucose carrier from human Hep G2 hepatoma cells have
been deduced from analysis of a complementary DNA clone
Mueckler et al., 1985). The deduced amino acid sequence Is in
good agreement with that reported for the purified erythrocyte-
glucose carrier. Analysis of the primary structure of the
deduced sequence of the glucose carrier from human Hap G2
hepatoma cell suggests the presence of 12 membrane-spanning
domains. I t was proposed that hydroxyl and amide side chains In.
several domains might participate in glucose binding or line a
transme mbrane pore through which the sugar move( Mueckler et
al., 1985).
Studies on the glucose carrier of other cell lines are
relatively few. Plagemann and his coworkers( Plagemann et al.,
1981 Graff, Wohlhueter and Plagemann, 1.981) suggested that
mammalian cell lines, such as Novikoff hepatoma cells, HeLa cells
and Chinese hamster ovary cells, possess hexose transport system
with directional symmetry. The effect of insulin on glucose
transport of adipocytes have also been examined( Suzuki and
Kono, 1980 Karniell et al., 1981 Kono et al., 1981 Kono et
al., 1982). Insulin can increase the glucose carriers on the
cell surface as well as glucose transport activity in adipocytes
3and this increase is primarily due to the translocation of the
transporter molecules from microsomal fraction to plasma
membrane. Recently, The glucose carriers of Ehrlich ascites
tumour cells have also been purified and identified as a
glycoprotein with a molecular mass range of 44,700 to 66,800
with a peak maximum at 52,000( McCormick and Jonstone, 1986).
Cytochalasin B Binding and Glucose Carriers
Cytochalasin B is a mold metabolite isolated from
Helminthosporium dematioldeum( Mizel Wilson, 1972) and has
been shown to prevent motility and cytokinesis in eukaryotic
cells by destroying the integrity of micro-filaments in the
contractile ring( Carter, 1967 Schroeder, 1968 Wessells et
al., 1971). Besides the above effects, cytochalasin B was found
to be a potent and reversible inhibitor of glucose uptake in
animal cells, such as human erythrocytes( Sogin and Hinkle, 1980
), adipocytes( Karnieli et al., 1981 Suzuki and Kono, 1980),
chick embryo fibroblasts( Salter and Weber, 1979) and L6
myoblast( Klip et al., 1982). It has been found that there
exists two classes of binding sites for cytochalasin B in bovine
red blood cells, HeLa cells and SV40 transformed mouse
fibroblasts( Lin et al., .1974). one of these two classes of
binding sites can be inhibited by D-glucose. This class of
binding sites was termed 'glucose-sensitive' binding sites. The
'glucose-sensitive' binding sites in mammalian cells have been
reported as being intimately related, if not identical to the
4glucose carrier on the cell membrane of these cells( Pinkofsky
et al., 1978).
Characterization o Glucose Sensitive tochalasin B B di
of Ehrlich Ascites Tumour cells
Cuppoletti, Mayhew and Jung (1981) first characterized the
glucose carrier of Ehrlich ascites tumour cells and found that
cytochalasin B competitively inhibits the carrier-mediated
glucose transport of Ehrlich ascites tumour cells. The
-7
inhibition constant (Ki) was about 5x10 M. They also found that
cy-tochalasin E cannot inhibit the carrier-mediated glucose
transport. When the cytochalasin B concentrations were up to
-5
1x10 M, the range where the inhibition develops to practical
completion, three discrete cytochalasin B binding sites with
different dissociation constants are distinguished. These three
binding sites are called L, M and H binding. The cytochalasin B
binding at L site shows a dissociation constant (Kd) of about
-6
1x10 M and represents about 30% of the total cytochalasin B
6
binding of the cell (8x10 molecules/cell). The L-site binding is
sensitively displayed by cytochalasin E but not by D-glucose, and
is located in cytosol. The cytochalasin B binding at M site
-7
shows a Kd of 4-6x10 M, represents about 60% of the total
7
saturable binding (1.4x10 molecules/cell), is membrane-bound and
specifically displaced by D-glucose with a displacement constant
of 15 mM, but not displayed by L-glucose, and is insensitive to
cytochalasin E. The cytochalasin B binding at H sites shows a Kd
5-8
of 2-6x10 M, represents less than 10% of the total sites 6
(2x10
molecules/cell), is not affected by either glucose or
cytochalasin E and is non-cytosol origin.
The binding of cytochalasin B to Ehrlich ascites tumour
cells was further characterized to have the following properties
(Chan, 1983):
(1) High affinity for cytochalasin B. The magnitude of Kd is
-7
10 M.
(2) Stereospecific inhibition by structurally related
carbohydrate such as D-glucose, 3-0--methyl-D-glucose, 2-
deoxy-D-glucose, D-galactose and D-mannose, whereas L-
glucose and D-f'-ructose are not effective.
(3) Sensitivity to other competitive inhibitors of glucose
transport such as phloretin and diethylstilbestrol.
Recently, the D-glucose sensitive cytochalasin B binding
system of Ehrlich asc i tes tumour cells has been purified and
reconstituted on liposomes( McCormick and Johnstone, 1986).
The reconstituted liposomes exhibited glucose transport activity
and cytochalasin B binding. This strongly indicated that the D-
glucose sensitive cytochalasin B binding sites might be the
putative glucose carriers.
Glucose Uptake of Ehrlich Ascites Tumour Cells
The glucose uptake in Ehrlich ascites tumour cells is
6mediated through two distinguished mechanisms, namely simple
diffusion and carrier-mediated facilitated
diffusion( Saha and
Coe, 1967 Kolber and Lefevre, 1967; Hatanaka, 1974). Both of
these two processes are energy independent and driven by the
concentration gradient of substrate across the plasma membrane
( Saha and Coe, 1967 Renner et al., 1972 Kaminska 1979). The
carrier-mediated facilitated diffusion of glucose in the cells
displays a saturable kinetic and follows the Michael is-Menten
equation. It may be adequately described by kinetic parameters
Vmax (maximal rate) and K-m (apparent half-saturation constant)
of the uptake process. An unsaturated kinetic is found in simple
diffusion and its rate of transport is directly proportional to
the substrate concentration.
The glucose uptake was initially measured by monitoring
the glucose disappearance rate in the incubation mixtures (Crane,
Field and Cori, 1956). However, this approach has many
shortcomings. It is difficult to see any difference in glucose
concentration between those before and after incubation, unless
the period of incubation is long enough, eg. 25-60 min.
Transient changes in glucose transport cannot be detected
(Kaminskas, 1979). In addition, this method can only measure the
total uptake of glucose. The contribution either by carrier-
mediated uptake or simple diffusion cannot be determined
individually.
Recently, the radioactive glucose analogs (e.g. 2-deoxy-D-
3 3
[ Hl-glucose, 3-0-methyl-D-[ H)-glucose etc.) have been used to
7measure the amount of glucose uptake in various cells ( Plagemann
and Richey, 1974; Chan et al., 1983). Since the radioactivity
could be measured with high sensitivity and the glucose analogs
are non-metabolizable, the initial rates of glucose uptake could
be accurately determined. Maximum velocity (Vmax) and Michaelis
constant (Km) of glucose uptake can then be evaluated.
The uptake experiments were performed in the absence and
presence of a competitive inhibitor of glucose uptake (e.g.
cytochalasin B) concurrently. As the uptake in the presence of
inhibitor is considered as passive diffusion, the difference in
uptake rates by the cells between these two conditions is
determined as carrier-mediated uptake.
Metabolic Characteristics of Ehrlich Ascites Tumour Cells
Ehrlich ascites tumour cells, like many other tumour
cells, have a characteristically distinct glucose metabolism from
those of normal cells. Even in the presence of oxygen, they
metabolize glucose mainly through glycolysis( Warburg, 1956).
A term "aerobic glycolysis" was devised to signify this abnormal
kind of glycolysis.
It is further found that Ehrlich ascites tumour are highly
dependent on glycolysis for the generation of ATP. only a very
small portion of metabolic energy (about 1%) is derived from
oxidative respiration( Lazo, 1981). Deprivation of glucose
8rapidly leads to a decreased ATP/ADP ratio, indicating a defect
in ATP regeneration and to a decreased adenylate energy charge
( Demetrakopoulos, 1978).
In addition to the main stream of glucose flux in the
glycolytic pathway, a small amount of glucose skeleton in Ehrlich
ascites tumour cells is found to flow into the pentose phosphate
pathway, either via oxidative branch or non-oxidative branch
(Fig. 1.1). The use of pentose pho-sphate pathway to provide ATP
is probably of very minor importanc-e in Ehrlich ascites tumour
cells( Lazo, 1981). The real role of this pathway is more
likely to provide( Gumaa and Mclean, 1969 Fabregat et al.,
1985) :
(1) a source for NADPH which serves as a reducing agent in the
biosynthetic process
(2) a mechanism for the formation of pentoses needed in the
synthesis of nucleotides.
As regard to the nucleotides synthesis, the ribose
phosphate portion of purine and pyr imid ine nucleotides comes from
5-phosphoribosyl-l-pyrophosphate (PRPP). PRPP is synthesized
from ATP and ribose-5-phosphate, which is primarily formed by
the pentose phosphate pathway. The pyrophosphate group is
transferred from ATP to C-1 of ribose-5-phosphate( Kornberg,
1954 Muray and Wong, 1.967).
9Fig.1.1 synthesis of PRPP by the oxidative and nonoxidative
pentose phosphate pathway. Glucose-6-phosphate may be
converted to PRPP either by the oxidative or non-




This reaction is catalysed by the enzyme 5-phosphorlbosyl-
1-pyrophosphate synthetase (ESC 2.7.6.1) and is an irreversible
process in intact cells( Henderson et al., 1965a).
Regulation o£ 5-Phosphorlbosyl-l-pyrophosphate (PRPP) Metabolism
The intracellular concentration o£ PRPP depends on a
balance between its formation and utilization. its synthesis is
regulated by the availability of precursor molecules, ATP and
ribose-5-phosphate( Henderson et al., 1965a; Wong and Murray,
1969). Murray and Wong (1967) showed that PRPP synthetase have
an absolute requirement of magnesium ion to function. They also
-2
demonstrated that Mg-ATP, instead of free ATP, is the true
substrate for the PRPP synthetase. It was reported that
inorganic phosphate is a required allosteric activator for
PRPP synthetase( Barankiewicz et al., 1977). in addition, the
synthesis of PRPP is also controlled by feedback mechanism.
Partial Inhibitions of PRPP synthetase can be obtained with amp,
ADP, GMP and IMP whereas slight or no inhibitions were obtained
12
with XMP, UMP, dUMP, CMP, dCMP or TMP( Wong and Murray, 1969).
Besides, PRPP itself does not affect the activity of PRPP
synthetase( Henderson et al., 1965a Wong and Murray, 1969).
Concerning the utilization of PRPP, 2 main types of pathways are
involved: (1) de novo synthesis of purine and pyr imid i ne
nucleotides( Bagnara, 1974 Henderson, 1962) (2) salvage
pathways of purine nucleotides converted the purines to the
respective nucleotides by using PRPP to attach a ribose phosphate
moiety to the base( Murray, 1966 Murray, 1967). In addition,
nonspecific enzymatic hydrolysis of PRPP was observed in human
tissue homogenates( Fox, 1974), suggesting that rate of PRPP
degradation may play a role in the steady concentration of
intracellular PRPP.
Role of PRPP in cellular metabolism
PRPP is an essential precursor for a number of divergent
metabolic pathway, for instance, the biosynthesis of purine,
pyrimidine, pyridine nucleotides and of histidine and tryptophan
( For reference, see Henderson et al., 1965 a, b, c). The
intracellular concentration of PRPP controls nucleotides
biosynthesis such that increases and decreases in PRPP levels
respectively accelerate and diminish this biosynthetic activity.
Pathological and pharmacological effects on the rate of purine
biosynthesis de novo in human tissue have been associated with
altered cellular levels of PRPP( Kelley, et al., 1970 Holmes et
al., 1973). Clinically, PRPP concentrations are elevated in
13
primary hyperuricemia with uric acid overproduction in the Lesch-
Nyhan Syndrome( Torrelio and Paz, 1979) and in gout resulting
from a partial deficiency of hypoxanthine-guanine phosphoribosyl-
transferase or a mutant PRPP synthetase( Becker et al., 1973).
Recently, Gay and Amos (1983) reported that the rate of glucose
transport and the intracellular PRPP are inversely correlated in
chick embryo fibroblasts. They further proposed that PRPP might
act as an 1 inactivator of the glucos-e transport system. However,
this hypothesis is not well-established and awaits for further
investigations. It is our interest in the present study to
examine the role of PRPP in the regulation of glucose transport
in Ehrlich ascites tumour cells.
Methods for Determination of PRPP
Different methods for determination of PRPP have been
de-scribed. Basically, two approaches are used. The first
method, (Kornberg, et al., 1955) using a spectrophotometric
assay, is dependent on the decrease in absorbance when orotate
reacts with PRPP in the presence of orotate
pyrophosphatransferase and orotidine-5-phosphate decarboxylase.
However, this method is suffering from the lack of sensitivity of
the spectrophotometric measure. The second method makes use of
the reaction of PRPP with radioactive bases catalyzed by the
appropriate pyrophosphoribo-transferases and the amount of
labelled nucleoside monophosphate formed is measured( Henderson
et al., 1965a Bagnara et al., 1973 Sadler and Switzer, 1977).
14
Because isotopically labelled bases of high specific activity are
available, this procedure can be used to detect nmol to pmol
quantities of PRPP. Later, Michelsen and Villadsen (1979) have
developed a very sensitive radioactive
microassay in which the
essential components of spectrophotometric o rotate removal assay
described by Kornberg et al (1955) were
3 employed but replacing
orotate with[ H]-orotate. PRPP assay performed in the present
study was basically according to the
principle of this procedure
but with several modifications (See Chapter 3).
Concerning the extraction of PRPP from intact cells, the
application of conventional procedures, for Instance, with
trichloroacetic acid or perchloric acid gives only very low
recoveries( Henderson et al., 1965a), which is primarily owing
to the acid lability of PRPP. An effective alternative has been
described by extracting PRPP from cells in Tris-EDTA buffer in
combination with rapid heating and cooling( Bagnara, et al.,
1973). EDTA should protect t-PRPP against the labilizing effect of
magnesium ion. Since heat can also increase degradation of PRPP
(Fig. 1.2), optimal heating period (30-45 seconds for EAT cells)
should be selected in order to minimize the loss during
extraction.
15
Fig.1.2. Yield of PRPP from EAT cells after various times of
extraction by heating in Tris-EDTA at 100° C.
Extraction of PRPP was performed as described in
Chapter 3, except that the time of heating was varied
as indicated. The results are compared with the









Most if not all tumour cells depend primarily on
glycolysis for the provision of energy. To maintain growth
potential, it is essential for these cells to possess a highly
efficient system for glucose transport. Any interference of the
glucose transport system may then affect the growth and survival
of the tumour cells. It is of interest to note that variations
in many environmental parameters, such as the nutritional
availability( Kaminskas and Nussey, 1979 Chan, 1983 )F
temperature( Giovanella et al., 1973 Plage-mann and Richey,
1974) or pH( Kaminskas, 1978) can induce changes in glucose
transport as well as the viability of tumour cells. The
regulation of glucose transport in tumour cells is, thus, worth
studying.
Various normal and tumour cell lines, when deprived of D-
glucose from their envir-onment, will manifest a striking adaptive
response by increasing the capacity of glucose transport
( Christopher et al., 1976 Musliner et al., 1977 Franchi et al.
,1978). Refeeding of glucose, by contrast, will suppress the
glucose transport activity back to the basal level( Martineau et
al., 1972 Amos et al., 1977 Leung, 1984). Previous kinetic
studies of transport indicated that the depression of transport
activity by glucose in Ehrlich ascites tumour cells is primarily
resulted from decrease of the number of glucose carriers on
plasma membrane( Leung, 1984). Using chick fibroblasts as an
18
experimental model, Amos et al. (1977) hypothesized that a
particular product of glucose metabolism should play a role in
promoting carrier inactivation in the regulation process.
Starvation of glucose upsets the formation of such product in the
cells, thus releasing the glucose carriers from inactivation.
Recent studies in chick fibroblasts have suggested that the 5-
phosphoribosyl pyrophosphate (PRPP) may be a potential candidate
for playing the role in the inactivation of glucose carriers on
the cell membrane( Gay and Amos, 1983). In this thesis, we
planned to examine this hypothesis. The Ehrlich ascites tumour
cells were used as an experimental model.
The inter-relationship among extracellular glucose
availability, intracellular PRPP concentration and glucose
transport capacity of Ehrlich ascites tumour cells were
investigated. in addition, certain metabolic drugs, namely, 2,4-
dinitrophenol and methylene blue were attempted to induce changes
in PRPP level and the drugs' effect on glucose transport activity
were examined.
We have reported that Ehrlich ascites tumour cells are
susceptible to many anti-tumour agents like methotrexate( Chan
et al., 1983) and tumour necrosis factor( Fung et al., 1985).
These agents can also decrease the glucose uptake rate of the
cells. Whether the intracellular level of PRPP could be affected
by these agents was also under investigations.
19
The change of another environmental parameter,
temperature, can also affect the tumour growth and membrane
transport activity( Giovanella et al., 1973 Plagemann and
Richey, 1974). Recently, the use of elevated temperature has
become a new trend in cancer therapy( Ardenne and Winfried 1982
f' However, the actual mechanism of lethal effect of
hyperthermia on the tumour is still uncertain. Due to the vital
role of glucose in the tumour growth, the change of glucose
transport activity under the hyperthermic treatment is worth
studying. In the present investigation, our attention was mainly
paid on the effect of the sublethal hyperthermic treatment on the
glucose transport system. The level of PRPP after such treatment
was also monitored.
It was reported that many chemicals can potentiate the
lethal effect of hyperthermic treatment( Bertino, 1984). In
this thesis, preliminary investigations in the combined effect of
hyperthermia and certain anti-cancer agents, such as
methotrexate, 5-flurouracil, cytarabine and tumour necrosis
factor are included. The combined effect of hyperthermia and
drugs (e.g. MTX and TNF) on the glucose transport system of




In this chapter, all materials used are listed and general
methods are described. Methods and procedures which were used
for special experimental purposes will be described in the
Experimental section of the related chapter.
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ICR strain of mice (30-40 g) were used. They were kept in
air-conditioned rooms and fed standard laboratory 'chow' and tap
water ad libitum.
Maintenance of Ehrlich Ascites Tumour Cell Line
Ehrlich ascites tumour, Ny Klein cell type, was maintained
by intrape_ritoneally implantation in mice. Mice bearing 7-day
old tumours were killed by cervical dislocation. Ascites fluid
containing tumour cells were aspirated from peritoneal cavity and
diluted with phosphate buffered saline (PBS). The cells were
collected by a table-top clinical centrifuge. The washed cells
7
were then resuspended in PBS to 5 x 10 cells/ml. 0.2 ml cell
7
suspension, which contains 10 cells, was injected
intraperitoneally into the normal mice. cell count was
determined with a haemocytometer.
Cell Culture methods
A. Culture Medium
The growth medium used for all cell culture studies was
RPMI 1640. Unless mentioned specifically, the medium was
prepared with double distilled water according to the
25
manufacturer's specifications and supplemented with 25 mm
HEPES and 25 mM NaHCO The medium was then sterilized
3
by passage through a 0.45 um Millipore filter and the
stored at 4°C. Sterility was tested by incubating the
filtered medium in culture tubes at 37°C for 3 days. Just
before use, the medium was further supplemented with 50
units/ml penicillin, 100 ug/ml streptomycin and 10% (v/v)
heat-inactivated fetal calf serum which had been incubated
at 56°C for 30 min.
B. in vitro study
Ehrlich ascites tumour cells were collected aseptically
from tumour bearing mice and immediately washed with
sterile PBS. Cells were then washed two times with half-
isotonic saline to remove the red cells, resuspended in
RPMI 1640 medium, and seeded in new culture flasks. The
suspended cells were incubated at 37°C for 4 hours before
further treatments.
C. Routine Passages of Cultured Cells
Ehrlich ascites tumour cells in culture were passaged
every 3-4 days by 10 fold dilution with fresh culture





The method as described by Chan et al. (1983) was
followed. Ehrlich ascites tumour cell suspension 2 7
( x 10 cells
/ml in PBS) were equilibrated to 37°C. At zero time, 0.2 ml cell
suspension was mixed with 0.2 ml of pre-warmed 2-deoxy-D-t 3H1-
glucose (1 uCi/umol) to give final concentrations of 0.1875 to
1.0 mM. Reaction was stopped after 6 sec by transferring 0.2 ml
of mixture to 1ml ice-cold PBS supplemented with 40 mm 2-deoxy-D-
glucose. Cells were collected by centrifugation at 15,000 g for
10 seconds in an Eppendorf 5414 microcentrifuge. The supernatant
was removed by aspiration and the cells were washed with 1 ml of
the same buffer. Cell lysis was accomplished by the addition of
0.2 ml 0.1% Triton X-100. 1 ml of Triton X-toluene scintillant
was added and the radioactivity counted in a Beckman LS-7000
liquid scintillation counter. Non-specific diffusion was
corrected by subtracting the uptake in the presence of 10 um
(final concentration) cytochalasin B. The kinetic parameters
Vmax and Km, representing respectively the maximal uptake rate
and apparent half-saturation constant for the specific transport
process, were determined by direct linear plot( Elsenthal,1974)
Equilibrium Binding of Cytochalasin 13
Equilibrium binding of cytochalasin B was performed
according to Cuppoletti, Mayhew and Jung (1981) with minor
modifications( Chan et al., 1983). For measuring total
27
7
binding, 10 cells in 1 ml PBS were incubated with 0.04 uci[ 3 Hl-
-7 -7
cytochalasin B and 1x10- 5x10 M cytochalasin B for 20 min at
room temperature. After the incubation, the cells were collected
by centrifugation at 15,000 g for 20 min. The radioactivities of
supernatant and pellet fractions were determined.
Cytochalasin B bound was calculated as% of total. To
assess the glucose-reversible binding of cytochalasin B, total
binding in the absence and presence of 500 mM D-glucose were
measured and the difference obtained. Maximal glucose-sensitive
binding (Bo) and the apparent dissociation constant (Kd) were
determined by Scatchard analysis.
Assay of 5-Phosphor ibosyl-l-pyrophosphate (PRPP)
The methods as described by Gay and Amos (1983) was used
with some modifications.
7
Ehrlich ascites tumour cells (2x10 cells/ml) were washed
with 5 ml ice-cold phosphate buffer saline (PBS) twice and then
collected by centrifugation. The cell pellet was resuspended
with 1 ml 50 mM Tris buffer, containing 2 mM EDTA. Cells were
subjected to extraction in the boiled water for 30 seconds and
cooled in the ice-water immediately after heating. The cell
debris were removed by centrifugation and the supernatant was
saved. Extract could be assayed immediately or stored at -20° C
(Under this temperature, PRPP is stable for 4 weeks).
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50 ul 17.8 mM Tris buffer (pH 8.0) containing 44 mM MgCl
3 2
and 1.5 uCi I H]-orotic acid was added to 50 ul of hot-water
extract. After which, 10 ul (0.007 unit) of enzyme mixture of
orotate pyrophosphoribotransferase and orotidine-5'-phosphate
decarboxylase (sigma 06250) was added. The mixture was allowed
to incubate at room temperature for 24 hours. Then, 10 ul (0.79
unit) of intestine alkaline phosphatase was added to the reaction
mixture and it was incubated for another 24 hours at room
temperature. 5 ul of mixture was chromatographed on
polyethyleneimine-cellulose plate (Merck) together with 50 nmol
ur id ine in n-butanol, methanol, water, 14.8 M NH water
3
(60:20:20:1 v/v). Orotate and uridine have Rf values of 0.00 and
0.37 respectively (Randerath et al., 1967). The uridine spot was
localized under UV light, cut out, extracted with 400 ul 2 M
ammonium water for 1 hr, and counted radioactivity in 3 ml
scintillant. The amount of PRPP was determined by comparing the
cpm of the unknown sample with that of a set of PRPP standards.
Measurement of Leucine, Uridine and Thymidine incorporation
Ehrlich ascites tumour cells were washed three times with
6
sterile PBS and resuspended with culture medium to 10 cells/ml.
100 ul cell suspension was added into each well of a 96-well
3
micro-titer plate (Falcon) and then mixed with 100 ul( H1-
3 3
leucine,[ Hi-uridine and[ HI-thymidine (10 uCi/ml). After
incubation at 37°C for 2 hours, the cells were harvested with
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saline through microfibre filters (Flow Lab). The filters was
subsequently washed with 5% trichloroacetic acid (TCA) and
absolute methanol. Filters were dried in air and placed in
scintillation vials containing 3 ml toluene-scintillant. The
radioactivities were measured with a Beckman LS-7000 liquid
scintillation counter. Background adsorption of radioactivity
was corrected by addition of radioactive precursors after
incubation and immediately before the harvest of cells.
Determination of Call Count and viability
Cell suspension of appropriate dilution was introduced to
the ruled counting area of a haemocytometer (American Opticals)
under the cover slip. The number of cells was counted with a
phase contrast microscope (Nikon) using the tally counter to
record numbers. Cell concentration in original suspension was
calculated accordingly. For the determination of cell viability,
the cells were stained with 0.3% trypan blue, and the unstained
(viable) and the stained (dead) cells were counted. Hence, the
viability is calculated from:
No. of viable cells
Viability 100%
Total no. of cells
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Production of Tumour Necrosis Serum TNS)
Methods as described by Ha et al. (1985) were used. Mice
4
was injected intravenously with y h 10 Listeria monocytogenes in
0.2 ml saline and challenged intravenously with 25 ug
lipopolysaccharide (LPS) in 0.2 ml saline 7 days afterwards.
Mice were bled from their subclavia n vessels 2 hours after LPS
injection. The sera were pooled, filter-sterilized, heated at 56°
C for 30 minutes and stored at -20°C until use. Control serum
was obtained from mice injected with Listeria and challenged with
0.2 ml saline.
Assay of Tumour Necrosis Factor
The original in vitro assay described by Carswell et al.
(1975) was to measure the viability of L-929 cells after TNF
treatment by trypan blue exclusion test. This method is slightly
5
modified in our laboratory (Ha et al.,1985). Briefly, 6.6 x 10
tumour cells (e.g. EAT L-929) in 0.5 ml complete RPMI 1640
medium were added to each well of a 24-well Falco plastic tissue
culture plate. 0.5 ml of complete medium with different
dilutions of TNF were added. The plates were incubated at 37° C
for 18 hrs. For suspension cultures (e.g. EAT), the viable cell
count was determined after addition 0.5 ml 0.3% trypan blue to
each well. For adherent cells (e.g. L-929), the culture medium
was removed, 0.2 ml 0.1% trypsin was then added and the mixture
was incubated at 37°C for 5 to 10 mans. After trypsinization,
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0.8 ml 0.1% trypan blue solution was added and the viable cell
count was determined by haematocytometer.
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Chapter 4
Effect of Glucose on Glucose Transport and
S-Phosphoribosyl Pyrophosphate (PRPP) Level
of Ehrlich Ascites Tumour Cells
INTRODUCTION
We have demonstrated that glucose can regulate its own
transport in Ehrlich ascites tumour cells( Fung et al., 1986
Leung, 1984). When D-glucose is deprived, a striking adaptive
response by increasing the capacity of glucose transport will
occur. Refeeding of D-glucose to th-e cells, by contrast,
decrease the transport activity back to the normal rate. This
phenomenon has also been found to -be common in many other tumour
and normal cell lines( Christopher et al., 1976 Musliner et
al., 1977 Franchi et al., 1978 Gay and Hilf, 1980). This type
of regulation was suggested as being an adaptive mechanism by
which the cells can surv-ive in certain unfavorably nutritional
environments. So, it has been termed as Adaptive Regulation of
Glucose Transport( Amos et al., 1977).
Our previous studies in Ehrlich ascites tumour cells
showed that the variation of glucose transport capacity, during
the adaptive regulation, is closely parallel to the change of
number of glucose ca-rriers on the plasma membrane( Chan et a l.,
1983a Leung, 1984). This data suggested that the suppressive
effect of glucose is primarily to induce change in number of the
glucose carrier on the cell.
Studies in chick embryo fibroblasts showed that the
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functional glucose carriers on cell membrane seemed to be
governed by the relative rate of carrier synthesis and
inactivation( Christopher et al., 1976 Yamada et al., 1983).
Amos et al.( 1977) showed that increase in transport capacity
which accompanied glucose depletion could be blocked by
cycloheximide treatment. They further proposed that 5
phosphorlbosyl-1-pyrophosphate (PRPP), an intermediate of glucose
metabolism, might serve as an Inactivator on the glucose
transport system( Gay and Amos, 1983).
To examine whether Ehrlich ascites tumour cells regulate
its tra-nsport in a similar manner as in chick embryo fibroblasts,
we studied the change of intracellular PRPP levels in face to
different extracellular glucose availabilities, and its
correlation to the glucose transport capacities. Cycloheximide
tre-atment was also included so as to evaluate the role of protein
synthesis in the de-repression of glucose transport.
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EXPERIMENTAL
TUMOUR DEVELOPMENT IN VIVO
7
1 x 10 Ehrlich ascites tumour (EAT) cells were injected
intraperitoneally into mice as described in Chapter 3 on day 0.
EAT cells were collected from the mice on day 2, 4, 6, 9 and 12.
At least 5 mice were included in each harvest. Cells were pooled
together and washed with half-isotonic saline in order to remove
red blood cells. The final cell suspension was prepared in PBS
for cytochalasin B binding and glucose uptake studies. Cell
numbers were counted and serum glucose was determined with
glucose kit 510 purchased from sigma.
TUMOUR DEVELOPMENT IN DRUGS-INDUCED DIABETIC MICE
30-35 gm male ICR mice were divided into 4 groups, namely,
control, diabetes, insulin-treated and insulin-treated diabetes.
In the diabetes group, mice were rendered diabetic either
by intravenously administration of alloxan (100mg/kg body
weight) or by intraperitoneally injection of streptozotocin
(200mg/kg body weight) three days before tumour inoculation.
Blood glucose of alloxan-treated or streptozotocin-treated mice
was determined before the inoculation of EAT cells in order to
ensure the diabetogenic effect of these drugs.
insulin treatment was performed according to the following
scheme: 4 IU/mouse of insulin were subcutaneously injected into
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mice 18 hrs before tumour inoculation, 4 IU/mouse at 18 hrs post-
transplantation and then progressively decreasing doses of 4 IU,
3 IU, 2 IU and 1 IU/mouse at 36 hrs intervals.
The insulin-treated diabetes group received both alloxan
/or streptozotocin and insulin administration as described above
whereas control mice was treated with PBS only.
All groups of mice were killed on day 7 after tumour
inoculation. Tumour cells were harvested, washed and the
equilibrium binding of cytochalasin B and intracellular PRPP
assay was performed. Cell numbers were counted and serum glucose
was determined.
PREPARATION OF GLUCOSE FREE CULTURE MEDIUM
Glucose free medium was prepared by mixing the individual
reagents according to the formula of RPMI 1640 medium (see
Appendix).
Heated inactivated fetal calf serum was dialyzed against 6
volumes of sterile saline for 12 hours. The dialysis were
repeated 4 times to ensure complete removal of glucose. Dialyzed
serum was sterilized by passage through millipore filter.
To prepare culture medium, glucose free medium was
supplemented with 5% dialyzed fetal calf serum, 25mM HEPES, 25mM




TREATMENT OF TUMOUR CELLS IN VITRO
Ehrlich ascites tumour cells were harvested from mice
bearing 7-day-old tumours. The cells were washed with ice-cold
5
PBS twice and then seeded at 5x14
cells/ml in glucose-free
culture medium supplemented with either glucose (15mM, 30mM and
45mM) or fructose (15mM). The cell suspensions were then
incubated at 37°C for 12 or 24 hrs. Cells were harvested by
centrifugation and washed two time with ice-cold PBS. The washed
cells were subjected for the cytochalasin B binding and
intracellular PRPP assay.
For the cycloheximide treatment studies, EAT cells (2x106
cells/ml) were incubated in glucose-free culture medium
supplemented with either 10mM glucose or fructose in the presence
or absence of cycloheximide (10 ug/ml). All 4 groups of cells
were incubated at 37°C for 12 hrs. Cells were then washed and




Fig. 4.1 Indicated that the number of Ehrlich ascites
tumour cells (EAT) increased during tumour development in vivo.
At the same time, EAT cells progressively increased their glucose
transport capacity (Fig. 4.2A and 4.2B). These result are
consistent with our previous findings( Chan, 1983 Chan et al.,
1983). The increase of glucose uptake rate (Fig 4.2A) appeared
to be primarily caused by the change in number of glucose
carriers (Fig. 4.2B), as there existed a good linear correlation
(r=0.983) between two transport parameters, Vmax (maximum glucose
uptake rate) and Bo (density of glucose- sensitive cytochalasin B
binding sites). At the same time, the Km value remained
relatively unchanged and so did Kd. The serum glucose
concentration of the EAT-bearing mice changed in an inverse
direction with Bo and Vmax during tumour development. The change
of intracellular level of PRPP of EAT cells was found to be
parallel with the alteration of serum glucose content (Fig.
4.2C), suggesting that the intracellular PRPP level in Ehrlich
ascites tumour cells might be regulated by the availability of
extracellular glucose.
Previous studies in phosphoglucose isomerase-deficient
hamster fibroblasts have emphasized the importance of pentose
phosphate pathway in the regulation of glucose transport
Pouyssegur, 1980 Ullrey, 1982). PRPP, being a product of ATP
and ribose 5-phosphate, was suspected to play a repressor role
in glucose transport.( Gay and Amos, 1983). The suppressive
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Fig. 4.1 Change of tumour size
of Ehrlich ascites
tumour cells in mice during development. For














Fig. 4.2: change o£ serum glucose of EAT-bearlng mice, PRPP level,
glucose-sensitive cytochalasin B binding and 2-deoxy-D-
glucose uptake in eAt cells during development. For
details, see experimental in this chapter.
A. Change of Vmax( ) and Km ( ) for 2-deoxy-
D-glucose uptake in EAT cells during tumour develop¬
ment.
B. Change of Bo( ) and Kd ( ) for glucose-
sensitive cytochalasin B binding in EAT cells during
tumour development.
C. Change of serum glucose concentration ( ) of
EAT-bearing mice and intracellular PRPP level
of EAT cells( ) during tumour development.
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role of glucose in its own transport in Ehrlich ascites tumour
cells has been confirmed in our laboratory( Fung et al., 1986).
It is of interest to investigate whether glucose exerts its
suppressive effect in EAT cells through its metabolic
intermediate, PRPP.
To test the above hypothesis, diabetes was artificially
induced in EAT-bearing mice by the administration of either
alloxan or streptozotocin and the effect of hyperglycaemia on the
glucose transp-Grt system- and intracellular PRPP level of EAT
cells were examined. Diabetes could suppress EAT growth in the
animals (Fig. 4.3A, 4.3B). Table 4.1 showed that alloxan-Induced
diabetes raised the serum glucose level from 80.0 to 202.6
mg/100 ml, and an 157% increase in the intracellular PRPP level
of EAT cells was found correspondingly. By contrast, the glucose
sensitive cytochalasin B binding sites of the cells (Bo) was
7
dropped from 211.2 to 102.4 pmol/10 cells. Insulin treatment on
diabetes partially reverse its stimulating effect on
intracellular PRPP level and restored the Bo value to a certain
extent. In non-diabetic EAT-bearing mice, insulin induced a mild
hypoglycemic effect, intracellular PRPP decreased while Bo of
the cells increased correspondingly. EAT-bearing mice induced
diabetes by streptozotocin and treated with insulin with the
same schedule as above gave similar results in changes of serum
glucose concentration, intracellular PRPP level and Bo of tumour
cells (Table 4.2). Again, intracellular PRPP level is directly
correlated to serum glucose level and inversely correlated to Bo
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Fig. 4.3: Effect of diabetes and insulin treatment on the tumour
growth of Ehrlich ascites tumour (EAT) bearing mice.
Mice were induced diabetes by alloxan (Fig. 4.3a) or
streptozotocin (Fig. 4.3b) 3 days before EAT
inoculation. EAT cells implantation and insulin
treatment followed the procedures described in
experimental. EAT cell counts were performed on day 7
after tumour transplantation. Data are presented as
Mean+ S.E.M. for 2 separate experiments.
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Glucose-Sensitive Cytochalasin B Binding and PRPP Levels of Ehrlich
Ascites Tumour Cells in Alloxan-Induced Diabetic Tumour-Bearing mice
serum Glucose PRPP Level Cytochalasin B Binding
Treatment (mg/l00ml) (% of control) Bo Kd
(pmol/107 cells) (10 -7 M)
Control 80.0+ 1.6 100 211.2+ 5.0 1.6+ 0.06
Alloxan 202.6+ 5.3** 257 102.4+ 10.5** 1.7+ 0.10
141.6+ 5.4**Alloxan 158.4+ 3.4** 196 1.7+ 0.07
+ Insulin
Insulin 62.6+ 0.5** 79 272.6+ 20.4* 1.7+ 0.09
Details of induction of diabetes by alloxan and treatment of insulin in
EAT-bearing mice were described in the experimental. Control were mice
bearing EAT cells without treatment of alloxan or insulin. Data are
presented as Mean+ S.E.M. for triplicate determinations of 2 separate
experiments.
PRPP levels are presented as per cent of control value.
p value for the significance of difference:




Glucose-Sensitive Cytochalasin B Binding and PRPP Levels of Ehrlich
Ascites Tumour Cells in Streptozotocin-Induced Diabetic Tumour-Bearing
Mice
Serum Glucose PRPP Level Cytochalasin B Binding
Treatment (mg/100ml) (1 of control) Bo Kd
(pmol/l07cells) (10-7 M)
Control 76.1+ 3.4 100 248.1+ 1.3 2.9+ 0.01
Streptozotocin 240.0+ 6.7** 169 98.8+ 5.7** 2.2+ 0.06
Streptozotocin 120.0+ 3.2** 120 151.1+ 2.6** 2.4+ 0.05
+ Insulin
Insulin 59.3+ 3.6* 90 267.7+ 8.3* 3.0+ 0.-1-8
Details of induction of diabetes by streptozotocin and treatment of
insulin in EAT-bearing mice were described in the experimental. Control
were. mice bearing EAT cells without treatment of streptozotocin or
insulin. Data are presented as Mean+ S.E.M. for triplicate
determinations of 2 'separate experiments.
PRPP levels are presented as per cent of control value.
p value for the significance of difference:
*p <0.05




In vitro experiments further confirmed the inter-
relationship among glucose availability, intracellular PRPP level
and glucose-sensitive cytochalasin B binding capacity (Bo) of EAT
cells (Table 4.3). PRPP level of cells decreased with the
decreasing glucose concentration in the medium. Substitution of
glucose by fructose (15mM) further decreased the PRPP level. The
Bo value, on the other hand, changed in an inverse direction with
respect to the concentration of glucose. No significant change
of Kd value could be observed.
in another experime-nt as shown in Table 4. 4, i t was
established that the increase in transport activity induced by
glucose deprivation requires protein synthesis as incubation of
EAT cells for 12 hours with cycloheximide significantly lowered
the capacity of glucose-starved cells to bind cytochalasin B
(p0.05). No apparent effect of cycloheximide on Bo for the
glucose-fed group could be observed. In addition, cycloheximide
treatment appeared to have negligible effects on PRPP levels of
the cells.
Table 4.3
Effect of Glucose Concentration on the Glucose-Sensitive
























- 6.6 120+ 6.9
-21.2 136+ 3.2
211.8+3.3 1.5+0.07 + 36.6 68+ 4.1
179.3+2.3 1.8+0.05
293.3+7.9 2.1+0.20 + 63.7
100
59+ 3.3
Ehrlich ascites tumour cells were incubated either with glucose or
fructose at indicated concentration for 12 hrs (Experiment 1) or
24 hrs (Experiment 2). The procedures were described in the
experimental. Data are presented as mean+. S.E.M. for 3
determinations.
PRPP levels are presented as per cent of that of 15mM glucose-fed
group in each experiment.
p value for significance of difference:
p<0.01
whfocompared W.ith :15rnMgluCose-fed group
p<0.001
Table 4.4
Effect: of Cycloheximlde on Glucose-Sensitive Cytochalasin B
















187.3+ 11.4 4.2± 0.92 100







Glucose-fed (10 mM) or fructose-fed (10 mM) Ehrllch ascites tumour
cells were Incubated with or without 10 ugml cycloheximlde for 12
hrs. Other procedures were described in the experimental. Data
are presented as Mean+ s.E.M. for 4 determinations.
PRPP levels are presented as per cent of that of glucose-fed group
p value for the significance of difference:
p>0.05 for the difference between glucose-fed and glucose+
cycloheximlde group




The transport of D-glucose in various normal and tumour
cells can be adaptively regulated by the availability of
extracellular glucose. The capacity of glucose transport was
found to be reversely correlated with the extracellular glucose
level( Matineau et al., 1972 Musliner et al. 1977
Consistent with these observations, our present and previous
studies have clearly demonstrated the suppressive effect of
glucose on its own trans-port in Ehrlich ascites tumour cells
( Chan, 1983 Chan et al., 1983 Leung, 1984). The mechanism of
regulation, however, is still unclear at present. It was
s-uspected that the metabolism of glucose beyond the 6-phosphoric
eater should be required for the glucose transport curb. This
was evident by the inability of non-metabolizable glucose
analogues, 2-deoxyglucose as well as 3-o-methylglucose, to down-
regulate the glucose transport process( Amos et al., 1977 Gay
et al., 1980 Kletzien, 1975).
Various studies have been done in order to find out the
potential metabolic pathway(s) Involved in the down-regulation.
The participation of glycolytic pathway as transport repressor
may be improbable, since a mutant strain of Chinese hamster
fibroblasts, defective in phospho-glucose isomerase, hence
exhibiting drastically curtailed glycolytic activity, proved as
responsive to glucose as was the wild type parental cell
(Pouyssegur et al., 1980). The importance of pentose phosphate
pathway, on the other hand, have been highlighted by the findings
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by Ullrey et al (1982) who showed that glucose flew predominantly
through the pentose phosphate pathway whereas glucosamine is
primarily routed through glycolysis in the phosphoglucose
isomerase -less mutant. They further proved that glucose, but not
glucosamine, is capable of repressing the transport in the
mutant. This data implicated the pentose phosphate pathway
and/or its intermediate(s) might serve as a potential regulator.
The role of exogenous glucose in the generation of
ribose-5-phosphate and 5-phosphoribosyl 1-pyrophosphate (PRPP)
have been investigated (Reltzer et al., 1980 vice et a-1.,
1981). Since PRPP is critical for sustaining nucleic acid
synthesis, and hence cell growth, the ribose phosphate pool was
suspected as the metabolic repressor stated above. A good
inverse correlation between the PRPP level and the rate of
glucose transport have been reported in cultured chick
fibroblasts( Gay and Amos, 1983). In the present studies, the
steady-state concentration of PRPP in Ehrlich ascites tumour cell
was monitored under a variety of environmental conditions In
order to elucidate its role in the regulation of glucose transport.
Development of Ehrlich ascites tumour cell in vivo could
exert a hypoglycemic effect on the host mice( Chan et al., 1983
Furthermore, the glucose concentration in ascites fluid
decrease from about 95 mg/100ml to apparently zero within the
first 48 hours post transplantation( Chan, 1983). From the time
on, tumour were under glucose starvation, and the availability of
glucose for the tumour cells depended on the delivery rate of
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serum glucose to ascites fluid. During the tumour development,
there was a progressive decrease in the serum glucose level and a
corresponding lowering in glucose delivery to tumour cells could
be resulted. The intracellular level of PRPP was found to
decrease with the serum glucose concentration during tumour
development (Fig. 4.2C), suggesting that its level might be
regulated by the availability of extracellular glucose. On the
other hand, the rate of glucose uptake (Fig. 4.2A) and the
density of glucose carriers of EAT cells (as determined by the
glucose-sen-sitive cytochalasin B binding) increased gradually
(Fig. 4.2B).
To further investigate this possibility, alloxan and
insulin were inj-ected to induce hyperglycemia and hypoglycemia in
tumour bearing mice. As expected, the Ehrlich ascites tumour
cells harvested from alloxan treated mice showed an increase in
PRPP level while Ehrlich ascites tumour cells obtained from
insulin-treated mice showed a reduction in PRPP level (Table
4.1). Though it has been reported that alloxan can induce
changes, either directly or indirectly, in different metabolic
pathways including the glycolysis and hexose monophosphate shunt
( Regen et al., 1964 Sochor et al., 1979 Sochor et al., 1984),
the possibility that this drug affected the PRPP metabolism of
Ehrlich ascites tumour cells directly seemed to be improbable
since it possess a very short half-life of only about 1 hr
(Rerup, 1968) and it was administrated on three days before
tumour inoculation. Moreover, the use of another diabetogenic
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compound, streptozotocin, have given a similar result as above
(See table 4.1 4.2). In addition, we had found that insulin had
no effect on the intracellular level of PRPP in Ehrlich as-cites
tumour cells in vitro (unpublished data). In conclusion, the
action of alloxan and insulin observed is likely to be exerted
indirectly through their effects on the serum glucose
concentration.
Growth of cells in vivo, nevertheless, might suffer from
a lot of complexities, which are mainly caused by a variety of
hormonal effects. It was re-ported that many kinds of hormones
could affect the PRPP metabolism in mouse liver cells( Lalanne,
1974). Therefore, for further characterization of the role of
PRPP on glucose transport, in vitro studies are essential.
Table 4.3 showed that there was a tendency of intracellular PRPP
to decrease with glucose concentration in the medium of EAT cell
culture. Substitution of glucose by fructose resulted in a
further decrease of PRPP level. This study further confirmed the
regulatory role of glucose in the generation of PRPP. Concerning
the glucose carrier density, Bo values decreased with increasing
PRPP contents and vice versa.
The synthesis of PRPP required the participation of
adenosine triphosphate (ATP) and ribose -5-phosphate (R-5-P) as
precursors( Kornberg, 1955). Starvation of glucose resulted in
a rapid loss of ATP within few hours in Ehrlich ascites tumour
cells( Demetrakopoulos, 1978). Due to the removal of glucose
source, the generation of R-5-P may also be retarded. So, it is
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reasonable to postulate that glucose deprivation results in
.removal of precursor molecules, both ATP and R-5-P, thus
hindering the synthesis of PRPP In Ehrlich ascites tumour cells.
Refeeding of glucose to the cells will restore the precursor
molecules, and in turn, the ability of PRPP generation.
The present studies showed that glucose suppresses its own
transport primarily through the change in the number of glucose
carriers on cell surface. Studies of glucose transport in
various cell lines revealed that the steady number of putative
glucose carriers on the cell membrane appeared to be determined
by the relative rate of carrier synthesis, carrier inactivation
( Yamada et al., 1983) and the incorporation of preformed
carriers from the Intracellular pool( Karnieli, 1981).
Interference of any of these three items might result In a net
increase or decrease in the number of functional carriers on the
cell surface and, in turn, the rate of glucose transport. we had
previously shown that actinomycin D displayed a suppressive
effect on glucose transport activity( Ng, 1985). our present
data showed that the de-repression effect induced by fructose can
be prevented by incubating the cells for 12 hours with
cycloheximide (Table 4.4). This findings suggested that new
carrier synthesis probably account for most of the increase
rather than translocation of pre-formed glucose carriers in
fructose-fed EAT cells. However, PRPP levels was not affected by
cycloheximide.
Details of mechanism for inactivation of glucose carrier
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of EAT cells are not yet known and may comprise of several steps
such as structural modification, internalization and subsequent
degradation( Amos et al., 1977 Kalckar et al., 1980 Yamada,
1983). However, as proposed before, it is evident that glucose
might exert its suppressive effect on its own transport through
the generation of certain metabolites( Gay and Amos, 1983
PRPP is a key Junction between carbohydrate metabolism and
nucleic acid synthesis. Its amount can highly reflect the
avai labi l it ies of metabolic energy and metabolizable carbon
source. Thus, it is conceivable that PRPP may act as a feedback
control signal in glucose- transport regulation. The present study
in Ehrlich ascites tumour cells, both in vivo and in vitro,
showed that the intracellular PRPP level could change directly
proportional to the extracellular glucose concentration, and
inversely proportional to the glucose transport capacities.
These findings appeared to lend supports to the above hypothesis.
However, the inverse correlation betwee-n PRPP and capacity of
glucose transport should not necessary imply a causal
relationship. Thus, the role of PRPP in the modulation of




Effect of 2,4-Dinitrophenol and Methylene Blue
on Glucose Transport and PRPP Level
of Ehrlich Ascites Tumour Cells
INTRODUCTION
It has been reported that in chick fibroblasts, the
glucose-mediated transport curb required metabolism of glucose
beyond the 6-phosphoric ester( Amos et al., 1977 Kletzien.,
1975). Studies were then directed to examine the metabolites in
different metabolic pathways of glucose metabolism In order to
find out the potential transport repressor. Previous studies in
many cell lines revealed that involvement of glycolysis or its
intermediate(s) in transport repression appeared to be Improbable
Kalckar et al., 1979 Pouyssegur et al., 1980). The pentose
phosphate pathway, as stated be-fore, is one of the potential
target under investigation at present( Gay et al., 1983).
Meanwhile, it has been proposed that the cells can regulate the
hexose transport according to their cellular 'energy state'. It
is evident by the observations that anoxia could initiate a
pronounced enhancement in glucose transport activity( Randall et
al., 1962 Reeves, et al., 1975). Furthermore, the uncouplers
of oxidative phosphorylation, such as 2,4-dinitrophenol and
oligomycin, are also able to elicit a marked increase of hexose
transport in glucose-fed cells( Kalchar et al., 1979). It was
assumed that the extracellular availability of hexose energy
source will affect the rate of Intracellular ATP generation,
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( Live et al., 1975) which may in turn act as a signal for the
hexose transport regulation. The oxidative phosphorylation, or
at least the 'energy state' is thus now be considered as one of
the main vector in the repressive regulation of glucose
transport.
This proposed issue, however, is controversial. Ozand et
al. (1962) showed that the enhancement of hexose transport during
anoxia state is not necessary involved the alteration of
intracellular ATP concentration. Besides, it was reported that
substitution of glucose by fructose did not induce significant
change in cellular ATP level of cultured Nil hamster fibroblasts,
however, the starved.-like derepression of hexose transport could
still develop( Rapaport, et al., 1979). It seemed that the
regulatory role of glucose in its own transport could not be
taken ac-count for solely by its effect on cellular 'energy state'
of cells.
Since the effect of anoxia and uncoupler on metabolism of
cell should be very board and not limited in the oxidative
phosphorylation( Takeda et al., 1967 Poole, 1968 Johnstone,
1978 Burckhardt et al., 1980), the intracellular level of ATP
might not be the single candidate responsible for the
derepression effect of these treatment. The pentose phosphate
flow, for instance, could also be altered significantly by
anoxia and uncouplers( Henderson, 1965a). Ehrlich ascites
tumour cells derived its metabolic energy from glucose primarily
through the glycolytic pathway( Warburg, 1956). The oxidative
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respiration, on the other hand, only take a very minor role in
ATP generation( Lazo, 1981). It was reported that treatment of
the uncouples, dinitrophenol, on Ehrlich ascites tumour cells
could not alter the intracellular ATP significantly in the
presence of glucose( Johnstone, 1978). So, it appears that
Ehrlich ascites tumour cells may be a useful model to elucidate
the role of uncouples in the modulating of hexose transport
activity. In the present study, the effect of 2,4-dinitrophenol
on the glucose transport capacity of Ehrlich ascites tumour cells
was examined. Particular attentions were paid on this
uncoupler's effect on the intracellular PRPP level.
In order to elucidate the role of pentose phosphate pathway
directly, a well-known electron acceptor, methylene blue
( Hershko et al., 1969) was used to activate the oxidative
decarboxylation of glucose-6-phosphate. Its effects on the




PREPARATION OF DRUG SOLUTION
The stocks of drugs were prepared by dissolving the 2,4-
dinitrophenol or methylene blue in the RPMI 1640 medium. The
solution was sterilized by passage through 0.45 um millipore
filter and stored at -20°C. In the studies, the solution was
further diluted with culture medium to desired concentration Just
before use.
TREATMENT OF TUMOUR CELLS IN VITRO
To investigate the concentration effect of drugs on the
5
growth rate and intracellular PRPP level, 5 x 10 cells/ml were
seeded into culture flasks. 2-2000 uM dinitrophenol or 0.2-200
uM methylene blue were added to the RPMI 1640 medium,
supplemented with 10% heated inactivated fetal calf serum, 2mM L-
glutamine, 30 mm glucose, 50 units/ml penicillin and 100 ug/ml
streptomycin. The cell suspensions were incubated at 37°C for 24
hours. Cells were then harvested and washed. The number of
viable cells was determined 'by trypan. blue exclusion method.
7
2x10 viabl-e- cells were then taken out for PRPP assay.
5
For the study of glucose transport capacity, 5 x 10
cells/ml were seeded and incubated with 400 uM dinitrophenol or
20 uM and 2 uM methylene blue in medium at 37°C for 24 hours.
Cells were then collected by centrifugation and subsequently
washed three. times with ice-cold PBS. The glucose-sensitive
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cytochalasin B binding and PRPP assay were determined as
described in Chapter 3.
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RESULTS
As shown in Fig. 5.1, the increase in 2,4-dinitrophenol
concentration accompanied a decrease in the PRPP level in EAT
cells. However, high concentration of 2,4-dinitrophenol, e. g.
2000 um, could resulted in a high rate of mortality. Cell
viability was found to be higher than 90% when the cells were
treated with of 2,4-dinitrophenol at concen-trations lower than
200 uM (Table 5.1).
400 uM of 2, 4 -dinitrophenol was chosen to study the drug's
effect on glucose transport of EAT cells. Cell viability under
this treatment was found to be 9-3.6%. An Increase of Bo could be
observed while the PRPP level was suppressed significantly (Table
5.2). The apparent Kd values for cytochalasin B binding were
unaffected when compared with that of untreated cells.
Cell number and viability decreased with the increasing
concentrations of methylene blue (Table 5.3). However, no
significant change in PRPP level could be observed at the same
time (Fig. 5.2). Treatment of 2uM and 20uM methylene blue
resulted in no apparent changes in both Bo and Kd values as well
as the intracellular PRPP levels of EAT cells (Table 5.4).
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Fig. 5.1
Dosage effect of 2,4-dinitrophenol on the
intracellular level of EAT cells in vitro.
Treatment of 2,4-dinitrophenol was described as
in experimental. Data are presented as Mean+










Dosage effect of 2,4-Dinitrophenol on the Growth and viability of
Ehrlich Ascites Tumour Cells In Vitro
Concentration of Viable Cell Viabilities
2, 4-dinitrophenol Count
(um) (x105 cells/ml)
0 11.1 0.62 98.4
2 10.6 0.31 97.9
20 9.5 0.91 96.2
200 9.7 0.34 97.3
2000 8.5 0.52 62.1
Treatment of 2,4-dinitrophenol was described as in experimental.





Effect of 2,4-dinitrophenol on Glucose-Sensitive Cytochalasin B
Binding and PRPP Level of Ehrlich Ascites Tumour Cells In Vitro
Treatment
Cytochalasin B Binding PRPP Level
Bo Kd (% of control)
(p mot/ 107cells) (10-7 M)
Control 215.1 10.1 1.25 0.08 100
2,4-Dinitro- 276.3 7.4* 1.21 0.07 39.6 1.-3
phenol
Treatment of 2,4-dinitrophenol {0.4 mm) was described as in the
experimental. The data were presented as Mean+ S.E.M. for
triplicate determinations for 2 experiments.




Dosage effect of Methylene Blue on Growth and viability of





0 11.1+ 0-.62 98.4
0.2 10.5+ 0.37 97.8
2.0 9.9+ 0.34 90.7
20.0 8.6+ 0.51 88.4
200.0 1.4 +0.61 20.1
Treatment of methylene blue was described as in experimental. The




Fig. 5.2: Dosage effect of methylene blue on the intracellular
PRPP level of EAT cells in vitro. Treatment of
methylene blue was described as in experimental.
Data are presented as Mean± S.E.M. for 3
determinations.
FIG. 5.2







Effect of Methylene Blue on Glucose-Sensitive cytochalasin B Binding
and PRPP Level of Ehrlich Ascites Tumour Cells In_ Vitro

















Treatment of methylene blue was described as in the experimental.
Data are presented as Mean+_ s.E.M. for 3 determinations for 2
separate experiments.
p value of significance for difference:




The hexose transport in most mammalian cells, includin
Ehrlich ascites tumour cells, was mediated mainly by the
facilitated diffusion mechanism, and does not require ATP and
other energy source to operate( Saha et al., 1967 Renner et
al., 1972 Hatanaka, 1974 Kaminskas, 1979 Jones et al., 1981).
However, it has been known for many years that anaerobiosis and
uncouplers of oxidative phosphorylation activate hexose transport
in many cells and tissues( Reeves et al., 1975 Randall et al.,
1962 Kalckar et al., 1979 Kalckar et al., 1980). Studies in
chick embryo fibroblasts also revealed that cellular ATP
utilization has a regulatory effect on hexose transport( Fagan
et al., 1978). So, it was suggested that the hexose transport
might be regulated by the bioenergetic state of the cells.
Ehrlich ascites tumour cells generate its metabolic energy
primarily through the glycolytic pathway( Warburg, 1956). It
was reported that treatment of 2,4-dinitrophenol could deprive
the cells of their ATP very rapidly( Postashner, 1971),
Indicating that this drug is effective in blocking the oxidative
phosphorylation of Ehrlich ascites tumour cells. However, in the
presence of glucose and dinitrophenol, ATP level can be
maintained which are similar to those in control cells
Potashner, 1971 Johnstone, 1978). It has been interpreted
that the high glycolytic rates of Ehrlich ascites tumour cell can
restore its intracellular ATP levels to normal.
In this study, we found that 2,4-dinitrophenol can
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increase the glucose-sensitive cytochalasin B binding sites on
the plasma membrane of Ehrlich ascites tumour cells, suggesting
that this treatment can increase the number of glucose carriers
on cell membrane. It seems to be inappropriate to take account
for this change by the cellular 'energy state' since high
concentration of glucose was included in the culture medium. It
is speculated that this drug up-regulates the hexose transport
through its 'side effects' on the cell.
Wu and Racker (1959) had reported that 2,4-dinitrophenol
can stimulate the lactic acid generation markedly in Ehrlich
ascites tumour cells within a short period. It was also found
that this drug can increase ATPase activities( Racker, 19-74).
Since ATPase activity drives glycolysis both in intact Ehrlich
ascites tumour cells and in an cell extract( Racker, 1983), it
was suggested that this uncoupler increased the glycolytic flow
through its effect on ATPase activities. The possibility that
involvement of glycolytic pathway as transport regulator has been
rejected by so many findings( Kalckar, 1979 Pouyssegur et al.,
1980). However, the rapid increase in glycolysis may cause a
reduction in the flow of glycolytic intermediates into the
pentose phosphate pathway, and hence, in the generation of
potential transport repressor, PRPP.
The effect of this uncoupler on the intracellular PRPP
concentration was then examined. As expected, this drug could
cause a drastic decrease in the PRPP level. 2,4-dinitrophenol
could- lower. the purine ribonucleotide synthesis, and thus may
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limit the PRPP utilization( Henderson, 1965b). So, the
decrease in PRPP level induced by 2,4-dinitrophenol might be
primarily explained in term of the synthesis of PRPP. This
uncoupler cannot inhibit the activity of phosphoribosyl
pyrophosphate synthetase( Henderson, 1965a). It is believed
that 2,4-dinitrophenol decreased PRPP synthesis by favoring the
formation of glycolytic intermediates so that les-s- ribose-5-
phosphate is available for PRPP formation. Moreover, this drug
could also prevent PRPP synthesis from the c-leavage of
ribonucleosides( Henderson, 1965c). whether the degradation of
PRPP (Fox, 1974) can be activated by 2,4-dini-trophe-nol is still
unknown.
The artificial hydrogen acceptor, methylene blue, rapidly
oxidizes NADPH to NADP and has been shown to stimulate the
oxidative branch of pentose phosphate cycle markedly in human
erythrocytes( Sciaki et al., 19-73) and Ehrlich ascites tumour
cells( Henderson et al., 1965a). In this study, the attempt of
using methylene blue to stimulate the PRPP synthesis, however,
was in vain. The failure in stimulation of PRPP synthesis might
be due to limited capacity of phosphoribosyl pyrophosphate
synthetase to accept the additional substrate formed in the
experimental condition( Henderson et al., 1965a). In addition,
this reagent can also act as an uncoupler of oxidative
phosphorylation in chick fibroblasts( Gay and Amos, 1983) and
3T6 fibroblasts( smith and Buchanan, 1979). It is possible
that this reagent can cause a reduction in the flow of glycolytic
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Intermediates into the non-oxidative branch of pentose phosphate
pathway thus rendering no significant change in the net
production of ribose-5-phosphate. Nevertheless, it should be
mentioned that this drug induced no apparent change in the number
of glucose carriers on the cell membrane as well.
In the last chapter, It has been described that
intracellular PRPP level can change with the availability of
extracellular glucose, but inversely correlates with the glucose
transport. However, this finding was not necessary to implicate
PRPP as the suspected transport repressor derived from glucose.
Therefore, An this study, change in PRPP level independent of
the extracellular glucose con-centration has been induced by
certain metabolic drugs. Though the use of methylene blue to
activate PRPP synthesis was not successful, the entire results
seems to lend further supports to the suppressive role of PRPP
in glucose transport. Further studies were then directed to find
out an effective PRPP enhancer, and to investigate its effect on
the glucose transport capacity of EAT cells.
Chapter 6
Effect of Anti-Cancer Agents on Glucose Transport
and PRPP Level of Ehrlich Ascites Tumour Cells
Part A: Studies on Methotrexate
INTRODUCTION
Methotrexate (MTX) has been used clinically as an anti¬




Methotrexate acts to competitively inhibit dihydrofolate
reductase, the enzyme that reduces dihydrofolate (FH) to
2
tetrahydrofolate (FH) in the presence of NADPH. Since
4
tetrahydrofolate is converted to a variety of coenzymes that are
necessary for the synthesis of thymidylate, purines, methionine
and glycine, inhibition of dihydrofolate reductase can lead to
inhibition of DNA, RNA, and protein synthesis( Stokslad and
Koch, 1967; Borsa and Whitmore, 1969; Bertino, 1970).
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A number of studies suggest that the critical effects of
methotrexate on tumour death are the inhibitions of thymidylate
synthesis and de novo purine synthesis. Thymidine monophosphate
is synthesized by transfer of one-carbon unit from N5 10-N
methylene-FH to deoxyuridine monophos-phate under the direction
4
of the enzyme thymidylate synthetase. After the reaction, the
folate coenzyme is oxidized and dihydrofolate is formed. To keep
system running, FH must be reduced to FH by the dihydrofolate
2 4
reductase. Inhibition of this enzyme by MTX will result in rapid
depletion of FH cofactor. The fol-ate being trapped in the
4 10
inactive FH form. Another folate, N -formyl-FH, involved
2 4.
In folate-dependent steps of purine synthesis is also depleted at
approximately 0.1 um of methotrexate( Smith et al., 1981). The
lack of thymidylate and purines blocks the synthesis of DNA.
Cellular proliferation in malignant tissue is greater than in
most normal tissue and thus methotrexate may impair malignant
growth more pronouncedly.
Ehrlich ascites tumour cells depend primarily on
glycolysis for the provision of energy( Live and Kaminskas,
1971). We have studied the effect of MTX on glucose transport
system of Ehrlich ascites tumour cells( Chan et al., 1983a Ng,
1985). MTX suppressed the glucose uptake rate, and reduced the
number of glucose carriers. The decrease in glucose carriers
closely paralleled and sufficiently accounted for the magnitude
of changes in glucose uptake. The inhibitory effect of MTX on
glucose transport may affect the mode of glucose metabolism and
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hence the growth potential of the cells. Kaminska and Nussey
(1978) have shown that MTX could produce an inhibition of
glycolysis and caused a defect in ATP generation in Ehrlich
ascites tumour cells. We( Ng, 1985) also demonstrated that MTX
arrested tumour growth of Ehrlich ascites tumour cells both In
vivo and in vitro. These findings may imply that glucose
metabolism is at least one of the important factors contributing
to the mechanism of actions of MTX in Ehrlich ascites tumour
cells.
The actual mechanism of MTX on regulation of glucose
transport of Ehrlich ascites tumour cells is not at all clear.
Studies by Ng (1985) suggested that MTX-inducing depletion of
nucleotides and the consequent inhibition of DNA, RNA and protein
synthesis might have constituted chain of events leading to
reduction in carrier synthesis. Besides, MTX inhibit de nova
purine synthesis and may disturb the metabolism of its precursor
molecule, 5-phosphoribosyl pyrophosphate (PRPP)( Cadman et al.,
1981). As proposed by Gay and Amos (1983), PRPP might be a
potential inactivator of hexose transport. So, it is of
interest to measure the intracellular level of PRPP In the cell
after MTX treatment.
MTX inhibits nucleotide synthesis and induces a
purineless state in the cells( Hryniuk, 1972). The growth
inhibitory effect of MTX can be reversed in the presence of
exogenous purine( Borsa and Whitmore, 1969 Hryniuk and Bertino,
1971 Kaminska and Nussey, 1978). Kaminskas (1979) further
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showed that hypoxanthine could prevent the inhibitions of 3-0-
methyl-D-glucose and of 2-deoxy-D-glucose uptake by MTX In
Ehrlich ascites carcinoma cells. Since administration of
exogenous purine can deplete intracellular PRPP level through the
salvage pathway( Murray, 1966 Murray, 1967), the change of




PREPARATION OF DRUG SOLUTION
The stocks of drugs (Methotrexate, 200 uM Hypoxanthine,
2mM) were prepared by dissolving the drugs in RPMI 1640 medium
and subsequently sterilizing by passage through 0.45 uM millipore
filter. The drug solutions were then stored at -20°c1. For the
studies, the solution were further diluted with culture medium to
desired concentration Just before use.
TREATMENT OF TUMOUR CELL IN VITRO
To investigate the dosage effect of MTX on glucose uptake
5
and intracellular PRPP, 5x10 cells/ml were seeded into the
culture flasks. 0.02 to 20 uM of methotrexate were added to the
culture medium (RPMI 1640), which was supplemented with 10%
heated inactivated fetal calf serum, 2mM L-glutamine, 30 mM
glucose, 50 units/ml penicillin and 100 ug/ml streptomycin. The
cell suspensions were incubated at 37°C for 24 hours. The cells
were harvested and washed three times with ice-cold PBS. The
7
final cell concentrations were adjusted to 2x10 cells /ml and
the 2-deoxy-D-glucose uptake and PRPP assay were performed.
For the study of hypoxanthine effect on glucose transport
5
of MTX-treated cells. Ehrlich ascites tumour cells (5x10 cells
/ml) were seeded and incubated with 2 uM MTX or/and 20 uM of
hypoxanthine in medium at 37°C for 24 hours. After incubation,
the cell number was counted with a hematocytometer. Cells were
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then collected by centrifugation and washed three times with ice-
cold PBS. 2-deoxy-D-glucose uptake, glucose-sensitive cytocha-
lasin B binding and PRPP level were then determined.
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RESULTS
Methotrexate (MTX) can suppress the glucose transport
activity in Ehrlich ascites tumour cells. This is clearly
demonstrated in table 6.1. Incubation of 20 uM or 2 uM MTX for
24 hours reduced Vmax of 2-DOG uptake process significantly
(p0.005) by about 40% and 27% respectively when compared with
that of untreated cells. MTX became ineffective in suppression
of glucose transport when its concentration was equal or lower
than 0.2 uM. In both control and drug treated groups, the Km
values remained relatively unchanged.
In table- 6.1, MTX has been shown to increase the PRPP
pools of Ehrlich ascites tumour cells in vitro. The increase is
well-related to the dose. Moreover, there exists a good inverse
correlation (r= -0.997) between PRPP level and Vmax.
The cell density of MTX-treated cells were partially
restored in the presence of hypoxanthine (Table 6.2). It is also
capable of depleting PRPP in control Ehrlich ascites tumour cells
in vitro (Fig. 6.1). The presence of this compound (20 uM) could
cause a moderate increase in rate of glucose uptake process
(Vmax) and glucose-sensitive cytochalasin B binding capacity (Bo)
of the cells (Table 6.3). Co-administration of 20 uM
hypoxanthine and 2 uM MTX prevented the accumulation of PRPP
Induced by MTX treatment. Meanwhile, Vmax and Bo were restored
to the normal values, as compared with that in untreated cells,
in a parallel manner. In all of these treatments, the value of
Km and Kd remained unaffected.
Table 6.1
Dosage Effect of MTX on 2-Deoxy-D-glucose (2-dog) Uptake and





























Treatment of MTX to Ehrlich ascites tumour cells were described
as in the experimental. Data are presented as mean+ s.E.M. for
2 separate experiments
PRPP levels are presented as per cent of that in control group.
The p value for the significance of difference:
p<0.005
p>0.05
when compared with control
Table 6.2
The Reverse Effect of Hypoxanthine on Tumour size of Methotrexate
Treated Ehrlich Ascites Tumour Cells In Vitro









Treatment of MTX and hypoxanthine were described as in the
experimental. Data are presented as Mean + S.E.M. for 2 separate
experiments.
d value for the siqniflcance of difference:
p<0.005
p>0.05
when compared with control
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Fig. 6.1: Dosage Effect of Hypoxanthine on the PRPP Level of
Ehrlich Asc i tes Tumour cells in vitro
Treatment of hypoxanthine in EAT cells was
described as in experimental. Data are presented
as Mean± S.E.M. for 3 determinations.










HYPoxanthine on the 2-deoxy-D-glucose Uptake and Glucose-Sensitive Cytochalasin










































Treatments of hypoxanthine and methotrexate were described as in experimental. Data
are presented as Mean+ S.E.M. for 2 separate experiments.
PRPP levels are expressed as per cent of that in control cells
p<value for the significance of difference:
p<0.05 for the difference between control and MTX group
p<0.05 for the difference between control and hypoxanthine group
p<0 05 for the difference between MTX and MTX+ hypoxanthine group
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DISCUSSION
The steady state of PRPP level can be viewed as a balance
of continuous synthesis and utilization of this compound( for
review, see Henderson et al., 1965 a,b,c). Increase of PRPP
level can be achieved either by increasing its synthesis or by
decreasing its utilization. The previous attempt in inducing
PRPP synthesis by methylene blue was failed, presumably due to
the limited activity of 5-phosphoribosyl pyrophosphate synthetase
(PRPP synthetase) under the experimental conditions. Inhibition
of PRPP utilization or modulation of the activity of PRPP
synthetase was, hence, considered as possible alternative to
achieve a high level of PRPP.
PRPP is a precursor molecule of purine and pyrimidine
bases, any interference to the synthesis or metabolism of the
bases may alter rates of PRPP metabolism. Methotrexate (MTX),
being an inhibitor of purine and thymidylate synthesis, may limit
the utilization of PRPP thus resulting in an increase of PRPP
pool. It was also reported that the activity of PRPP synthetase
was under control of feedback inhibition by purine nucleotides
( Bagnara et al., 1974). MTX suppresses de novo synthesis of
purine bases and s-ubsequently leads to depression of purine
nucleotides formation, which may, in turn, release the PRPP
synthetase from feedback inhibition. Since PRPP itself cannot
affect the activity of PRPP synthetase( Wong and Murray, 1969),
continuous synthesis of PRPP may be allowed even a high
concentration of this compound is accumulated inside the cells.
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However, it was also reported that MTX treatment could cause a
defect in ATP generation in Ehrlich ascites tumour cells
( Kaminska and Nussey, 1978). Since ATP is one of the precursor
molecules of PRPP, it is possible that MTX can also retard the
formation of PRPP. Hence, the actual effect of MTX on
intracellular PRPP level is required to examine.
Study by Cadman et al. (1981) has revealed that MTX can,
in fact, induce great enhancement in intracellular PRPP( 2 to 8
times of control values following concentrations of MTX between
0.1 uM to 10 uM) in L1210 cells. This finding may imply that
the degree of MT-X-induced suppression on PRPP utilization is much
greater than that on PRPP synthesis in L1210 cells. Also, in
the present investigation, an significant increase in PRPP level
did occur in Ehrlich ascites tumour cells exposed to MTX. This
increase was found to be well-related to the dose. On the other
hand, the Vmax decreased in face to the increasing MTX
concentrations. Since Km values remained relatively unchanged in
both control and MTX-treated groups, qualitative changes in the
affinity of glucose and its transport component in the cells need
not be invoked.
For a further study, hypoxanthine was added to alleviate
the effect of MTX on PRPP accumulation. Hypoxanthine can deplete
the intracellular PRPP for conversion to IMP by the MTX-
insensitive salvage pathways, thus preventing PRPP from
accumulating inside the cells after MTX treatment. No
significant change in PRPP level, as compared with control, could
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be observed when hypoxanthine was co-administered with MTX
(Table 3). Meanwhile, the suppressive effect of MTX on glucose
transport activity was also counteracted by the treatment of
hypoxa-nthine. The roughly parallel restoration of tumour size
and glucose transport capacity (Table 2 and 3) observed in the
hypoxanthine plus MTX treated cells suggests that the retardation
of glucose transport may have a role in the cytotoxicity of MTX
treatment.
As discussed before, PRPP Is a potential transport
inactivator derived from glucose. So, it is reasonable to
assume that the suppression of glucose transport by MTX may, at
least partly, share a common mechanism with the down regulation
of glucose transport by glucose itself. Nevertheless, the
situation is complicated by the fact that MTX can also induce
depletion of nucleotides and consequently inhibit DNA, RNA and
protein synthesis. So, the reduction in glucose carrier-s on
pla-sma membrane after MTX treatment may be the result of the
above chain of events and need not relate to the increased PRPP.
In addition, treatment of hypoxanthine in MTX-treated Ehrlich
ascites tumour cells might not only deplete the accumulated PRPP
but also partly restore the nucleotides synthesis and in turn,
DNA, RNA and protein synthesis. Hence, no conclusive deduction
can be drawn from the present study. It appears that further
studies are still required to elucidate the role of PRPP in the
regulation of glucose transport.
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Part B: Studies on Tumour Necrosis Factor
INTRODUCTION
Tumour necrosis factor (TNF) was first discovered by
Carswell and her colleagues( Carswell et al., 1975) as a
substance in serum of mice infected with bacillus Calmette-Guerin
(BCG) and subsequently challenged with endotoxin. Later, it was
shown that sera from animals, injected with various strains of
Plasmodia( Clark et al., 1981), Corynebaterium parvuin( Green
et al., 1977), Mycobater ium lepraemur ium( Ha et al., 1983 )f
Listeria monocytogenes( Ha, et al., 1985), Propion-}bacterium
Bloksma et al., 1983 Haranaka et al., 1984), Zymosan
Haranaka et al, 1984) and sheep red blood cells( Satoh et al.,
1986) and subsequently challenged with endotoxin also contained
TNF activity. TNF induced necrosis of certain tumours in vivo
and was cytotoxic or cytostatic for many tumour cells in vitro
( Matthews, 1981 Ruff, et al., 1981).
Despite of the intensive studies on TNF performed in the
last decade, the mechanism of action remains obscure. Studies
in vivo revealed that TNF containing serum (TNS) can modulated
numerous immunological function in mice( Hoffmann et al., 1978)
to induce the production of natural killer cells( Chun et al.,
1979) and to increase the cytotoxicity of lymphoid cells
Pasanen, 1979). Nevertheless, in vitro studies clearly showed
that TNS must also exert a direct cytotoxic action on the tumour
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cells. We have shown that TNS could cause leakage on the plasma
membrane( Fung et al., 1985). Whether such membrane
derangement can affect various membrane transport processes is,
thus, an interesting subject to study. We have demonstrated that
increases of calcium and uridine uptake took place in the TNS-
treated L-929 cells( Fung et al., in press). Moreover, TNS
could cause a significant decrease in the rate glucose transport
in Ehrlich ascites tumour cells( Fung et al, 1985).
For most of the investigations on the mode of action of
TNF, crude or partially purified TNF preparation were used. So,
these studies are subjected to certain reservations that the
effects- observed may have some contributions from contaminations
present in the TNF containing serum. Recently, a highly purified
human TNF (rhTNF) Is available by the recombinant DNA
technology( Pennica et al., 1984). So, It is of interest to
use this gene product to re-examine the actions of TNF.
In the present study, we examined the effect of rhTNF on
glucose transport activity of Ehrlich ascites tumour cells in
vitro. our previous studies have revealed that the TNF
containing serum can suppress the glucose uptake rate in a manner
similar to glucose and MTX, i.e. by lowering the density of
putative glucose carriers on the plasma membrane( Leung, 1984).
Whether the rhTNF can also affect the glucose transport and
intracellular level of the potential transport inactivator,
PRPP, of the Ehrlich ascites tumour cells, is an object to study.
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EXPERIMENTAL
The effect of purified recombinant human TNF (rhTNF)
obtained from Genentech Co. (USA) on growth of cultured Ehrlich
ascites tumour cells was examined. EAT cells were seeded a5 t 1.7
x 10 cells/ml in supplemented RPMI 1640 medium as described in
Chapter 3 and incubated with 100X, 500X and 10000X diluted rhTNF
(Concentration of rhTNF stock: 5.02 x 107
u/ml) at 37°C for 48
hours. At different time intervals, aliquots of cells were taken
out for cell counting. viability of cells was assayed by trYPan
blue exclusion method.
Ehrlich ascites tumour cells (2 x 10 5 cells/ml) were seeded
in supplemented RPMI 1640 medium. Cells were then incubated with
5
1 x 10 u/ml rhTNF (i.e. 500X dilution) at 37°C for 30 hours.
After incubation, cells were harvested, washed and adjusted to 2
7
x 10 cells/ml. 2-deoxy-D-glucose uptake, glucose-sensitive
cytochalasin B binding and PRPP assay were performed.
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RESULTS AND DISCUSSION
Fig. 6.2 showed that recombinant human TNF (rhTNF) could
inhibit growth of Ehrlich ascites tumour cells. This growth
inhibitory effect exhibited a dose dependent manner (i.e. higher
doses of rhTNF resulted in lower cell concentrations).
5
500X diluted rhTNF (1 x 10 a/ml) was chosen to study this
agent's effect on glucose transport of EAT cells. It is clearly
shown from table 6.4 that rhTNF can suppress the carrier-mediated
glucose transport in Ehrlich ascites tumour cells. The
observation that there existed a roughly parallel change in Bo
and vmax while the Km and Kd values remained relatively no change
indicated that the decrease of putative carriers sufficiently
account for the decreased rate of glucose uptake in rhTNF-treated
cells. This is consistent with the findings in which TNF
containing serum (TNS) was employed( Leung, 1984), suggesting
that TNF rather than the contaminants present in TNS, was the
primary cause of the suppression of glucose transport.
rhTNF cannot induce significant change in intracellular
PRPP level of Ehrlich ascites tumour cells (Table 6.4).
Therefore, decrease of glucose transport is not necessary taken
place together with an .increase in PRPP in EAT cells.
Nevertheless, this finding do not reject the possibility that
PRPP may be an inactivator of glucose transport. In fact, the
density of glucose carriers on the plasma membrane is regulated
by a complex manner in which the carrier synthesis, carrier
93
Fig. 6.2 Effect of rhTNF on EAT cell growth in vitro. 1.7 x 10 5
2
cells/ml of EAT cells were seeded in 25 cm culture
flasks. Viable cell concentrations in the culture
incubated with 10OX ( ), 500X( ), 10000X
( ) diluted rhTNF (original rhTNF concentration:
7
5.05 x 10 u/ml), or medium( ) at indicated
times were determined. The res-ult are expressed as
the average of three determinations.
TIME OF INCUBATION (hr)
Table 6.4
Effect of Recombinant Human Tumour Necrosis Factor (rhTNF) on 2-deoxy-D-glucose
Uptake and Glucose-Sensitive Cytochalasin B Binding and Intracellular Level of















Control 26.9+ 0.0 1.9+ 0.05 178.5+ 12.1 2.7+ 0.31 100
rhTNF
k k
17.4+ 4.8 1.0+ 0.53 107.4+ 2.4 1.5+ 0.01 101+ 0.1
Treatment ofrhTNF was described as in experimental. Data are presented as Mean+
S.E.M. for 2 separate experiments.
PRPP levels are expressed as per cent of that in control cells.




Inactivation and incorporation of carrier onto the plasma
membrane may probably involve. It seems that no single mechanism
can account for all of the cases. It is possible that the
suppression of glucose transport in Ehrlich ascites tumour cells
by rhTNF may not share a common mechanism with the down-
regulation of glucose transport induced by glucose itself or by
other anti-cancer agents (for example, MTX).
We have demonstrated that Ehrlich ascites tumour cells is
a very susceptible cell line to TNS( Fung et al, 1985). we
also reported that the transplantability of Ehrlich ascites
tumour cells was abolished as soon as 4 hours after exposure to
TNS. Ehrlich ascites tumour cells depend primarily on glucose
for their energy metabolism (Lazo, 1981). Deprivation of glucose
resulted in a rapid depletion of cellular ATP( Live and
Kaminskas, 1975). Any interference of the glucose transport may
thus affect the growth potential of the cells. so, it is possible
that the cytostatic or cytotoxic effect of TNF may be, at least
partly, contributed by its suppressive effect on glucose
transport. Concerning this notion, the susceptibilities of other
tumour cells, which depend mainly on respiration for their energy
metabolism, to TNF Is worth examining.
97
Chapter 7
Effect of Hyperthermia on Tumour Growth and
Glucose Transport of Ehrlich Ascites Tumour Cells
INTRODUCTION
The biologic rationale of using heat in the treatment of
cancer has been studied for many decades. However, technical
problems associated with heating human tumours have limited the
clinica-1 implementation and therapeutic evaluation of this
modality. With the modern advance in the development of precise
and well-controlled bioheat transfer device( Lahmann, 1982), the
interest in hyperthermic treatment of cancer is renewed.
Previous studies in vivo revealed that at least some
malignant cells tend to be more heat-sensitive than the normal
cells( Lavaliere et al., 1967 overgaard, 1977). It is also
frequently suggested in literature that the process of malignant
transformation is associated with an acquisition of heat
sensitivity( Chen and Heidelberger, 1969 Giovanella et al.,
1973). These findings highlight the clinical significance of
such modality in the cancer therapy. Hyperthermia affects most
cellular functions, including the inhibition of synthesis of DNA,
RNA and protein( Mondovi et al., 1969 Henle and Leeper, 1979).
Increase of lysosomal activity has also been observed( Turano et
al., 1970 Warters and Henle, 1982). This may be the cause of
cytoplasmic damage that lead to the immediate tumour death during
heat treatment. Recently, we studied the change of carrier-
mediated glucose transport system In Ehrlich ascites tumour cells
after a period of sublethal hyperthermic treatment. Whether such
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a change in glucose transport contributes to the lethal effect of
hyperthermia is still under investigation.
The potential of using hyperthermia to enhance the anti-
proliferative effects of chemotherapeutic drugs and antitumour
agents has been noted. The effect of many drugs against tumours
are amplified if drug administration is combined with
localized heating of-tumours( Ciovanella, et al., 1970 Marmor,
1979 Chitinis, 1986). The mechanism by which heat increases
the effect of drugs may be an increase uptake of drugs into the
tumour cells( Bertino, 1984) or/and a synergistic effect of
heat and drugs on the cells Dickson and Shah, 1972 Braun and
Hahn, 1975 Overgaard, 1976). Therefore, it is of interest to
study whether the combined treatments of hyperthermia with anti-
cancer drugs can exert any additive/or synergistic effect on the
glucose transport system of the tumour cells. In addition,
hyperthermia inhibits the entry of tumour cells into mitosis(
Cavalliere et al., 1967). Phase specific drugs may then selected
in order to obtain greater therapeutic effect. The effect of
tumour necrosis factor may also be of interest. The appropr iate
combinations of these treatments on experimental tumour cells are
also under investigation.
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Effect of Hyperthermic Treatment on the viability of Ehrlich
Ascites Tumour (EAT) Cells In vitro
Methods
Ehrlich ascites tumour cells were obtained from 8 day old
tumour-bearing mice as described in Chapter 3. Tumour cells
were then resuspended with phosphate buffered saline solution, pH
7. 4 (P-BS) or RPMI-1640 medium and suspended in the same buffer at
7
1x10 cells/ml. Cell were incubated at 37°, 41°, 43°, 45°C for
various time intervals. The viability of cells after treatment
was determined by trypan blue exclusion methods.
Results
Fig. 7.1.a shows the viabilities of EAT cells incubated in
PBS at various temperatures. Cell incubated at 37°C for 6 hrs
served as control. Cells treated with hyperthermia at 41°, 43°
and 45°C showed various degrees of cell death from 2 hrs onwards
after incubation. Fig. 7.1.b shows that similar results were
obtained when cells were incubated in RPMI 1640 culture medium.
It is clear that hyperthermia is effective in killing EAT cells
in vitro.
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Fig. 7.1: Effect of Hyperthermic Treatment on the viability of
Ehrlich Ascites Tumour Cells In vitro
7
a. EAT cells (1x10 /ml) were incubated in PBS
at 370, 41°, 430, 45°C for various time intervals.
I
b. EAT cells (1x10 /ml) were incubated in RPMI 1640
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Effect; of Hyperthermic Treatment on the Transplantablllty of
Ehrllch Ascites Tumour Cell
Ehrlich ascites tumour cells were prepared as described In
last section. EAT cells were then resuspended in RPMI 1640 medium
6
at 5x10 cellsml. Cells were incubated at either 37°C or 43° c
for various time intervals. After incubations, cells were
collected, washed and administered to mice. For each single
7
administration, 1x10 viable cellsmouse were inoculated i.p.
into 15 mice. Five of them were killed on day 0 and the tumour
sizes were determined. The average survival period of the rest
10 mice was also recorded.
Results
Table 7.1 shows the tumour sizes on day 8 and average
survival period of the host mice after inoculation of the treated
EAT cells. Pre-incubation of cells at 43°C for longer than 1 hr
before inoculation completely abolished their trans-
plantabilities. in contrast, incubation of cells at 37°C under
the same condition for 3 hrs caused no significant change both in
tumour sizes on day 8 and the viability of the tumour bearing
mice as compared with the non-treated group.
Methods
Table 7.1
Effect of Hyperthermic Treatment on the Transplantabi1lty of







































Untreated 1.70+ 0.12 15.7
EAT cells (5x106cellsml) were incubated either at 37 C or 43 C
for various time intervals. After incubations, cells were
washed and implanted into normal mice each with 1x107 viable
celis.
Tumour cells were harvested on day 8 post-transplantation and
counted with hematocytometer. Data are presented as Mean±_ S.E.
M. for 5 determinations.
The average survival periods of the rest tumour bearing mice
were also recorded.
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Effect of Hyperthermic Treatment on Thymidine Uridine and Leucine
Methods
Ehrlich ascites tumour cells (5 x 106 c ells/ml in RPMI
1640 medium) were prepared as described in last section. Cells
were either incubated at 37° C or 43 0 C for various time
intervals-. After incubations, cells were collected by
centrifu-g-ation and washed with RPMI 1640 medium. Incorporation
of radioactive precursors, namely, thymidine, uridine and
leucine, in EAT cells were then performed as described in chapter
3.
Results
The incorporation of radioactive precursors, namely,
thymidine, uridine and leucine into EAT cells as a function of
incubation time is shown in fig. 7.2. Incorporation rate at 43°c_-.
is expressed as in percentage with respect to the values obtained
with the cells incubated at 37°C. It is clearly shown that
hyperthermic treatment (43°c1) can exert marked inhibitory effect
on incorporation of these precursors. Longer incubation, period
results in higher inhibition rate. When the incubations at 43° C
were prolonged to 1.5 hrs, inhibitions reach 80-95%.
Incorporation of Ehrlich Ascites Tumour Cells In Vitro
Fig. 7.2 Effect of hyperthermic treatment on the incorporation
of thymidine( ), uridine ( ) and leucine
( ) in Ehrlich ascites Tumour (EAT) cells.
6
EAT cells (5x10 ml) were incubated at either 37°C or
43 °C from 0 to 3 hours. Cells were taken out at
various time intervals. After washing, thymidine,
uridine, leucine incorporation were determined as
described in Chapter 3.
incorporation is defined as:
Incorporation after preincubation at 43°C
Incorporation after preincubation at 37°C












Period of Treatment (hrs.)
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Effect of Hyperthermic Treatment on Glucose Transport and Intra-
cellular Level of PRPP of Ehrlich Ascites Tumour cells In vitro
Methods
Ehrlich ascites tumour cells (5x10 6 cells/ml in RPMI 1640
medium) were prepared as descried in last section. Test cells
were incubated at 43°C for 1.5 hrs. Cells incubating at 37°C for
the same period were used as control. After incubations, the
cells were collected by centrifugation and washed twice with ice-
7
cold PBS. The final cell concentrations were adjusted to 2 x10
cells/ml in PBS. The 2-deoxy-D-glucose uptake, cytoch.alasin B
binding as well as PRPP assays were performed as described in
chapter 3.
Results
Table 7.2.a shows the rate of carrier-mediated 2-deoxy-D-
glucose uptake, capacity of glucose sensitive cytochalasin B
binding by EAT cells after hyperthermic treatment at 43°C for
1.5 hrs. The carrier mediated 2-deoxy-D-glucose uptake rate
(Vmax) was significantly decreased (-415) in cells after heat
treatment( 43° C). In addition, the cytochalasin B binding
capacity (Bo) was also decreased but with a lesser extent (-11%).
No significant change in the Km and Kd values could be observed.
Besides, the simple diffusion remained relatively unchanged after
the hyperthermic treatment (Table 7.2.b).
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Table 7.3 shows the PRPP level after hyperthermic
treatment. It appeared that incubation at 430C for 1.5 hrs did
not result in significant change in the intracellular PRPP level.
Table 7.2.a
Effect of Hyperthermia on the Carrier-Mediated 2-deoxy-D-glucose
Uptake and Glucose Sensitive Cytochalasin B Binding Capacity of





















19.1+2.63 1.87+0.01 213.6+4.8 2.46+0.05
11.3+0.68 2.03+0.07 189.7+5.4 2.37+0.03
6
EAT cells (5x10 cellsml) were incubated at either 37°c or 43°c
for 1.5 hrs. Cell were then washed and assayed for carrier-
mediated uptake and cytochalasin B binding.
Values are presented as Mean+_ S.E.M. for 3 determination of
two separate experiments
p values for significance of difference:
P<0.01
Table 7,2.b
Effect of Hyperthermia on 2-Deoxy-D-glucose Uptake by Simple












EAT cells (5x106 ml) were incubated at 37°C or 43° C for 1.5
hours. Cells were then washed and adjusted to 2x107ml in PBS.
The 2-DOG uptake by simple diffusion were assayed by incubated
the cells with 3mM[ 3H]-2-Deoxy-D-glucose for 6 seconds at 37° C
in the presence of 10 uM of cytochalasin B.
Data are presented as Mean+. S.E.M. for two separate experiments.
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Table 7.3
Effect of Hyperthermic Treatment on Intracellular PRPP Level of
Ehrlich Ascites Tumour Cells In vitro
Incubation PRPP Level




EAT cells (5x10 /ml) were incubated either at 37°C or 43°C for
1.5 hrs. Cells were washed and assay of PRPP were performed.
Data are presented as Mean+ S.E.M. for two separate experiments
6
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Combined Treatment- Hyperthermia and chemotherapy on Ehrlich
Ascites Tumour Cells In vitro
Methods
Ehrlich ascites tumour cells were prepared as described
in last section. Cells were then resuspended in PBS at
7
1x10 cells/ml. Methotrexate (2 uM), or 5-fluorouracil (10 uM) or
cytarabine (10 um) in PBS were added. The cells were there
incubated at 37° C, 41° C, 43°C and 45° C for various time
Interval-s. The viabilities of the cells were determined by
trypan blue exclusion. Cells incubated in the ab-sence of any
drug were used as control.
Fig. 7.3 shows that there was no significant effect of
drugs on the treatment from 37°C to 45°C for 1 hr. However, when
the treatment was prolonged to 2-3 hrs, these drugs exhibited
enhanced lethal effects on the cells (Fig. 7.3-7.5), For example,
while close to 80% of the cells survived in incubation at 45° C
for 3 hrs in the absence of drugs, addition of either of three
drugs cau-sed the viability percentage to plummet to below 20
(Fig. 7.5). When cells were treated hyperthermically for 5 hrs,
all cells died at 45°C whether drugs were present or not (Fig.
7.6).
F1q. 7,3-6: Combined Effects of Hyperthermia and Methotrexate or 6
Fluorouracil or Cytarabine on viabilities of Ehrlich
Asc i tes Turnour Cells I n Vi t r q
Methotrexate (2uM), or 5-Fluorouraci1 (lOuM) or
7
Cytarabine (IGuM) were added to EAT cells (1x10 ml in
PBS). Cells were then incubated at 37°, 41°, 43°, and
45°C for various time intervals.
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Combined Treatment- Hyperthermia and Tumour Necrosis Serum/ or
Recombinant Human Tumour Necrosis Factor on Ehrlich Ascites
Tumour Cells In Vitro
Methods
7
Ehrlich ascites tumour cells (1x10 cells/ml in PBS) were
prepared as described in the last section. Tumour necrosis factor
containing serum (TNS) were obtained and assayed as described in
chapter 3. The EAT cells were divided into three groups and
different TNS and control sera preparations were added: group 1,
PBS (control) group 2, 500X dilution of control serum group 3,
500X dilution of TNS (initial TNS titre: 500-1000). The cells
were incubated at 37°C and 43°C for various time periods. The
viabilities of cells were measured trypan blue exclusion method.
For the study of recombinant human TNF (rhTNF), the cell
suspensions were prepared as described above. Cells were
incubated with PBS (Control) or rhTNF (250X dilution) or rhTNF
7
(1000X dilution) (Stock concentration of rhTNF 5.02 x- 10
u/ml). The cells were incubated at 37°C and 43°C for various
time periods. The viabilities of cells were determined.
Result
Fig. 7.7.a shows that, there was no change in viability of
cells with or without TNS at 370C. However, at 430C the TNS
treatment resulted in sortie enhanced cytotoxic effects after 2
hours of incubation (Fig. 7.7b). The synergistic effects were
also observed when rhTNF was used instead of TNS (Fig.7.8.a &
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7. 8. b). rhTNF with higher conceritr,.t lon (250X) could not further
enhanced the cytotoxic effect under hyperthermic treatment.
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Fig 7.7: Effect of Combined Treatment of Hyperthermia and Tumour
Necrosis Serum (TNS) on the vi alb l i t i es of Ehrlich
Ascites Tumour Cells In Vitro
7
EAT cells (1x10 /ml in PBS) were incubated with 500X
diluted control serum or 50c0X ddiluted TNS( initial TN
titre: 500-1000) either at 37°C or 43°C for various
periods.
a. Effect of TNS on the viabilities of EAT cells at 37°c




























Fig. 7.8: Effect of combined Treatment of Hyperthermia dnd
Recombinant Human Tumour Necrosis Factor (rhTNF) ort
the viability of Ehrlich A5cites Tumour Cells in
Vitro
7
EAT cells (1x10 /ml in PBS) were incubated with rhTNF
(250X or 1000X dilution the concentration of stock
7
rhTNF is 5.2 x 10 a/ml) at either 37°C or 43° C for
various time intervals. Viabilities of cells wire
measured.
a. Effect of hypertherrriia and rhTNF on the viability of
EAT cells at 37°C
b. Effect of hyperthermia and rhTNF on the viability of
EAT cells at 430C
PBS
rhTNF( 10 0 0 X)
rhTNF (250X)
























Combined Effect of Hyperthermia and Methotrexate on 2-deoxy-D--
glucose Uptake of Ehrlich Ascites Tumour Cells In Vitro
Methods
Ehrlich ascites tumour cells were harvested aseptically
from mice bearing day 7 tumour cells. After washing twice with
5
sterile PBS, 5 x 10 cells/ml Ehrlich ascites tumour cells were
seeded in RPMI 1640 medium, supplemented with 10% heated
inactivated fetal calf serum, 2 mM L-glutamine, 30 mM glucose, 50
units/ml penicillin and 100 ug/ml streptomycin. The cell
suspensions were incubated at 37°C for 21 hrs. MTX (2 uM) was
added either at the beginning or at the end of Incubation.
Afterwards, cell suspensions were placed at 37°C or 43° C for
further 3 hrs. Cells were then collected, washed and adjusted to
7
2 x 10 viable cells/ml. The 2-deoxy-D-glucose uptake was
performed.
Results
Table 7.4 showed the effect of hyperthermia alone and in
combination with MTX on the rate of glucose uptake (Vrnax) of
Ehrlich ascites tumour cells. Control cells were incubated at
37° C for 24 hrs (group a). Separate treatment of e i ther
hyperthermia (43°C) for 3 hrs (group b) or MTX at 37°C for 24 hrs
(group c) can result in 51.2% or 20.9% decrease in Vmax values
respectively when compared with that of the control cells. Co-
treatment of hyperthermia with MTX for 3 hrs (group f) and
treatment of hyperthermia for 3 hrs alone (group b) decreased the
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rate of glucose uptake (vmax) to a similar extent. However, if
cells were pre-incubated with MTX for 21 hrs (group d), combined
heat-MTX treatment could have an additive effect on the decrease
of Vmax of EAT cells. In both heat-treated or/and MTX-treated
groups, the apparent Km values for glucose uptake were unaffected
when compared with that of control cells.
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Table 7.4
Combined Effect of Hyperthermia (43°C) and Methotrexate (MTX) on
the 2-deoxy-D-glucose Uptake of Ehrlich Ascites Tumour Cells In
Vitro
Treatment Period of 2-deoxy-D-glucose
Treatment Uptake
vma x K titTemperature (°C)
2 1 tics :3 hrs (nmo l /rain/ 1 O 6 ce 1 l s) (mM)
a
PBS 37 20.4 1.04 2.4 0.1737
PBS b
2.4 0.729.9 0.5537 43








EAT cells (5 x 10 /ml) were pre-incubated at 37°C for 21 hrs.
Equal volume of MTX (0.2 uM, final concentration) or PBS was
added either at the beginning or at the end of incubation. Cells
were then incubated at 37° C or 43° C for further 3 hrs.
Afterwards, the 2-deoxy-D-glucose uptake of cells were determined.
Data are presented as Mean± S.E.M. for 2 separate experiments.
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combined Effect of- Hyperthermia and Recombinant Human Tumour
Necrosis Factor on 2-deoxy-D-glucose uptake of Ehrlich Ascites
Tumour cells In vitro
Methods
Ehrlich ascites tumour cells were prepared as described in
5
last section. EAT cells( 2x 10 /ml) were incubated at 37°C for
27 hours. Recombinant human tumour necrosis factor (rhTNF) (5 x
410 u/ml) was added either at the beginning or at the end of
incubation. Afterwards, cell suspensions were placed at 43°C for
further 3 hrs. Cells were then collected, washed, adjusted to 2
7
x 10 viable cells/ml and subjected to 2-deoxy-a-glucose uptake
assay.
Results
Table 7.5 showed the effect of hyperthermia in combination
with rhTNF on the rate of glucose uptake process. Cells
subjected to hyperthermia alone for 3 hrs was used as control.
of hyperthermia with rhTNF for 3 hrs caused a 20'x,
co-treatment
decrease in Vmax as compared with that of the control cells. If
EAT cells were pre-incubated with rhTNF for 27 hrs prior to the
inhibition of glucose uptake by combined
heat treatment,.
treatment of heat and rhTNF became more pronounced (up to 47).
heat-rhTNF treated groups, the apparent Km values for
In both
glucose uptake were unaffected when compared with that of the
control cells.
Table 7.5
Combined Effect of Hyperthermia (43°C) and Recombinant Human
Necrosis Factor (rhTNF) on 2-deoxy-D-glucose Transport of Ehrlich




























EAT cells (2 x 105ml) were preincubated at 37°C for 27 hrs.
rhTNF (5 x 104uml) was added either at the beginning (Pre-
treatment) or at the end of incubation (Co-treatment).
Afterwards, cell were placed at 43°C for further 3 hrs. Cells
were then subjected to the 2-deoxy-D-glucose uptake determination.
Data are presented as Mean+ s.E.M. for 3 determinations
p value the significance of difference:
p 0.01
p 0.001
when compared with control
a+: presence of rhTNF




Exposure of Ehrlich ascites tumour cells to elevated
temperatures eventually resulted in cell death. The
effectiveness of cell killing appeared to be a function of
temperature and length of heating period. Higher temperature and
longer heating period lead to higher death rate (Table la, b)
At present, the mechanism of cell death at elevated temperatures
still remains unknown. Hyperthermic treatment in the range of
,41°--46°C inhibits RNA, DNA or protein synthesis( Henle, 1919),
damages DNA( waarters and Henle, 1982 Warters et al., 1985),
inhibits oxidative respiration( Mondovi et al., 1969a) and
induces heat-shock proteins( S-ciandra and Subjeck, 1983 Landry
et al., 1985), but nonce of them has been shown to causally
related to the immediate cell death under heat treatment. on the
other hand, ultrastructural l-studies of solid tumour treated with
hyperthermia have revealed that heat treatment could rapidly
induce the development of lysosomes in the tumour cell cytoplasm
( Overgaard, 1976). A pronounce-d lysosomal enzyme activity was
also observed in the cytoplasm of the tumour cells during the
first few hrs after heat treatment( Turano et al.,1970
Overgaard, 1976). Since lysosomes, with their content of
hydrolytic enzymes, are capable of carrying out degradative
processes on most cellular components, and possibly on the whole
cellular structure. It seemed to be a potential candidate to
cause the cytoplasmic damage that lead to tumour degeneration
during hyperthermia.
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The study of transplantability of Ehrlich ascites tumour
cells after hyperthPrmic treatment is of interest. Although over
85% of cells remained viable after incubation at 43°c1 for 1.5
hrs (as assessed by trypan blue exclusion), their
transplanta bility was completely abolished (Table 7.1). The
inability of treated EAT cells to survive in the host mice may
relate to the depression of DNA, RNA and protein synthesis. In
fact, our data (Fig. 7.2) showed that hyperthermic treatment (430
G for 1.5 hrs) could suppress the incorporation rate of
precursors, thymidine, uridine and leucine to a very low level
(80-95% inhibitions). However, this issue is still controversial
since some experimental observations indicated that both the
nucleic acid synthesis and protein-synthesis could prefectly re-
established within one or two days after heat treatment( Simard
and Bernhard, 1967 Warocquier and schemer, 1969 Love and
Walsh, 1970). Besides, the enhanced lysosomal activity in heat
treated cells might be another possible cause for the loss of
transplantabil ity.
The plasma membrane has also been suggested as a possible
target of hyperthermia( Hahn, 1982). Elevated temperature cart
modify the fluidity of plasma membrane( Anderson et al., 1981)
which may in turn affect the membrane transport activity. we
have observed that hyperthermic treatment can markedly suppress
the rate of carrier-mediated glucose transport in Ehrlich ascites
tumour cells (Table 7.2.a). Since the growth of Ehrlich ascites
cells depends primarily on glucose( Lazo, 1981), suppression of
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gglucose uptake mtmiyht decrease the energy supply to thre cancer
cells and suppress their growth ability when re-Implanted into
the animals. However, further studies are required to elucidate
this hypothesis.
The mechanism of transport inhibition is not at all clear.
However, the fluidity or structure of membrane of Ehrlich ascites
tumour cells did not appear to have been damaged by hypertherrric
treatment sinc-e the uptake of 2-deoxy-D-glucose uptake through
simple diffusion had remained unchanged after treatment (Table
7.2b). Qualitative change in the affinity of glucose and its
transport component in the cells also need not invoked since no
apparet1t change in Km and Kd value' could be observed,
Furthermore, it was observed (Table 7.2.a) that the decrease in
Vmax (-41t) was much more pronounced than decrease in Bo (-11t,),
so the decreased transport activity cannot be Lu.olely accounted by
the reduced number of functional carriers on the cell nerrbra- ne.
Some other unknown mechanisms might also involve in the
inhibition.
Hypertheriflic treatment( 4 3° C for 1. 5 h-irs) did not cause
significant change in intracellular PRPP level, indicating that .a
decrease in glucose uptake is not necessary accompany an increase
in PRPP level, If PRPP is the assumed inact ivator of glucose
transport in the glucose induced transport curb, the present
result may imply that down regulation of glucose transport by
glucose itself and by hyperthermic treatment need not share a
common mechanism.
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The potential of usinq hypertherrnia to potentiate the
therapeutic effect of anti-cancer agents has been well-documented
(For review, see Bertino, 1984). However, the possible role of
combined treatment of hyperthermia and drugs in the tumour
lethality has not been established with certainty. In fact, it
is d i f f i c u l t to generalize about the combination of hypertherrnia
with cytotoxic drugs of different nature. Interactions need to
be cons Idered for Individual or at best groups (f drugs with
similar modes of actions. Therefore, our investigations on the
combination of hyperthermia with drugs were started with a group
of S-phase specific drugs (i .e. rnethotrexate, 5-fluorouracil,
cytarabine). The preliminary results indicated that the efficacy
of those drugs on Ehrlich ascites tumour cells could be enhanced
by hyperthermnlc treatment. These f Indirigs have Initiated c:ur
interest to explore whether there exists any additional effect on
the glucose transport activity of the tumour cells under the
combined heat-drug treatment. Since the effect of rnethotrexate
on the glucose transport system of Ehrlich asp, i tes tumour cell s
has been well-studied in our laboratory (Chan et al., 1983), it
w,as selected as a representative of this group of drugs in the
Investigation. co-treatment of hypertherrnia (43° C) with MTX for
3 hours gave a similar degree of suppression in glucose transport
of EAT cells as what given by the treatment of hypertherrnnia (43°
C) for hrs alone, indicating that no additional effect (?n
glucose transport could be obtained by this combination. As
--- to the fact that cell k i lls due to MTX is highly
tiripe-dependent and long exposure to this drug is required for
optimum cell klll( Ng, 1985), pre-incubation of MTX for 21 hrs
prior to the heat treatment were also performed. An additive
effect on suppression of glucose transport could really be
observed under this treatment. This finding may have certain
clinical implications in the design of treatment schedule when
the combination of this drug and hyperthermia are employed in
cancer therapy. Investigation of the combined effect of
hyperthermia and other phase-specific chemotherapeutic drugs
(e.g. drugs specific for Gl, G2 phase) on the growth and glucose
transport activity of certain animal and human tumour cell lines
a r e now in p ro gross.
En hanc e d t u mou r killing effect wa s a 1s o o bse r ve d in E AT
cells treated with hyperthermia (43°c) in combination with tumour
necrosis factor containing serum (TNS) or recombinant human
necrosis factor (rhTNF). The synergistic effect on tumour
lethality has been noted from 3 hrs onwards after incubation
(fig.7.7, 7.8). In addition, co-treatment of hyperthermia (43°C)
with rhTNF for 3 hrs can also result in an additional decrease in
glueose uptake when compared with that of cells sub1ected to 43
C alone (Table 7.5). Due to the vital role of glucose in EAT
cells, it is possible that the additionally suppressive effect on
glucose transport might partly contributed to the synergistic
tumour killing under such a combination. Moreover, the
suppression of glucose transport could be further enhanced in
case that the cells were pre-treated with rhTNF prior to the
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heat treat rient, again, suggesting that the efficiencies of




General Discussion on the Role of PRPP
In Regulation of Glucose Transport
in Ehrlich Ascites Tumour Cells
The correlation between intracellular PRPP level and
carrier-mediated glucose transport of Ehrlich ascites tumour
cells under a variety of experimental conditions has been
monitored in the present study. The results are concluded as
follows:
(1) Intracellular. PRPP level could increase with the avail-
ability of extracellular glucose, and inversely correlated
with the carrier-mediated glucose transport.
(2) Treatment of 2,4-dinitrophenol, an well-known uncoupler,
caused a reduction in the intracellular pool of PRPP and,
at the same time, elicited a marked increase in the number
of glucose carriers on the cell membrane. on the other
hand, methylene blue, an electron acceptor which was used to
enhance the oxidative branch of pentose phosphate pathway,
did not induce any apparent change in both PRPP and number
of glucose carriers.
(3) Methotrexate (MTX), a folate analogue, is capable of
inducing an accumulation of intracellular PRPP. Carrier-
mediated glucose transport was suppressed by the
administration of this drug. Hypoxanthine prevented the
accumulation of intracellular PRPP in MTX-treated cells, and
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restored the glucose transport activity to normal.
(4) Recombinant human tumour necrosis factor (rhTNF) suppressed
carrier-mediated glucose transport but did not affect the
intracellular PRPP level.
(5) Hyperthermic treatment (43°C for 1.5 hours) markedly
suppressed the rate of gluco-se transport, however, no
significant change in PRPP co-uld be observed under this
treatment.
Results of (1), (2) and (3) reveals a good inverse
correlation between glucose transport and PRPP level. These
findings appears to support the inactivator role of PRPP in
the suppressive regulation of glucose transport. Nevertheless,
it should be kept in mind that the inverse correlation need not
imply a causal relationship. In fact, the effect of various
drugs used in the study (e.g. 2,4-dinitrophenol, MTX,
hypoxanthine) have been proved to be very broad and not unique to
affect the PRPP metabolism. It is possible that glucose
transport might be altered by the side effects of those drugs.
Thus, more specific metabolic drugs( e.g. drugs which directly
act on PRPP synthetase) should be required in further studies.
Results of (4) and (5) indicate that decrease of glucose
transport is not necessary accompanied an increase in PRPP.
However, these findings do not reject the possibility that PRPP
act as an inactivator of glucose transport. It may merely imply
that the suppression of glucose transport by rhTNF or by
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hyperthermic treatment do not share a common mechanism with the
down regulation of glucose transport by glucose itself.
Gay and Amos( 1983) have shown that purines or their
nucleosides, in particular guanine and guanosine, can
dramatically deplete the intracellular PRPP pool in chick
fibroblasts. Moreover, addition of guanine decreased the glucose
transport in glucose-fed chick cells, but did not affect the
increases observed in cells starved for glucose. on the other
hand, guanosine or its analogues could sharply decrease transport
in both glucose-fed and glucose-starved chick fibroblasts. It
has been speculated that (1) the nucleoside (i.e. guanosine)
provides sufficient ribose-5-phosphate for synthesis of PRPP, and
hence of 5'-GMP and (2) a nucleotide of guanine may be important
in repression of glucose transport. In the present study, the
effects of guanine, together with guanosine, on glucose uptake
and intracellular PRPP level of Ehrlich ascites tumour cells have
also been examined. I t is obviously shown from table 8. 1 that
both guanine and guanosine are capable of depleting intracellular
PRPP and decreasing the rate of glucose transport In glucose-fed
Ehrlich ascites tumour cells. Whether the guanine nucleotides
take place in the physiological regulation (e.g. adaptive
regulation) of glucose transport in normal cells and tumour
cells is, thus, an object of further studies.
Until now, we have so much evidence indicating that
glucose or certain metabolite (s) of its metabolism (probably be
PRPP) can regulate the density of putative glucose carriers on
Table 8.1
Effect of Guanine and Guanosine on 2-deoxy-D-glucose Uptake and






















Ehrlich ascites tumour cells (5xl05cellsml in supplemented RPMI
1640 medium as described in Chapter 3) were incubated with either
guanine (50 uM) or guanosine (50uM) at 37°C for 24 hours. After
incubation, the cells were harvested, washed and resupended in
PBS at 2xl07cellsml. The 2-DOG uptake and PRPP assay were
performed as described in Chapter 3.
Data are present as Mean+ S.E.M. for 2 separate experiments
PRPP level are presented as per cent of that of control value
p value for significance of difference:
p 0.05
p 0.001
when compared with control
142
the plasma membrane of Ehrlich asc i tes tumour cells. However,
the mechanism of action is unknown. Christopher and his co-
workers (1976a, b) proposed that regulation in glucose carriers
involves the turnover of components of glucose uptake system on
one hand and glucose carriers synthesis which may or may not be
alternatively accelerated and restrained on the other. Amos et
al. (1977) showed that glucose (or its metabolites) acts as a
repressor at a posttranscriptional step probable at the level of
turnover of pre-formed carrier. The protection of pre-formed
carrier in the absence of glucose and by inhibitors of protein
synthesis even in the presence of glucose has encouraged
conjecture that a protease is activated by a metabolic product of
glucose that is analogous to corepressor. The metabolite either
activates the protease by direct interaction with it or alters
the conformation of carrier molecules to expose a critical region
to protease attack. The regulation of carrier density in
membrane may be achieved entirely by carrier inactivation, the
rate of which is a function of availabilities of extracellular
glucose. whether PRPP substains the hypothesized metabolic
inactivator role in this two-components transport inactivation
model is still uncertain. Moreover, whether this repression and
derepression hypothesis in regulation of glucose transport also




The regulation of glucose transport in Ehrlich ascites
tumour (EAT) cells was examined in this thesis.
The phenomenon that glucose regulates its own transport is
c-ommonly observed in various normal and tumour cells (Amos et
al., 1977 Gay and Hiff, 1980 Chan et al., 1983 Fung et al.,
1.986). Consistent to the above studies, the present data show
that glucose exerts its regulatory effect on glucose transport of
EAT cells directly. High concentration of glucose down-regulates
the number of glucose carriers on the plasma membrane in EAT
cells and vice versa.
The physiological importance of this kind of regulation in
EAT cells is obscure. However, it is reasonable to hypothesize
that it might be an adaptive mechanism by which the cells can
survive in certain unfavorably nutritional environments. As the
amount of available glucose decreases, EAT cells elaborate more
glucose carriers as a compensatory response.
Though the regulatory role of glucose In its own transport
has been f irm-ly established, the exact action site (s) of
regulation is not at all clear and remains to be identified. The
present study demonstrates that protein synthesis is required in
the derepression of glucose transport during starvation.
However, whether the rate of carrier synthesis can be modulated
by the change of glucose concentration is required to examine.
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The possibility that the translocation of glucose carriers
between the plasma membrane and intracellular pool might be
affected by extracellular availability of glucose should also be
explored. Previous studies on various cell lines such as, chick
fibroblasts( Amos et al., 1977), Nil cells( Mandel and Amos,
1984) and phosphoglucose isomerase-deficient hamster fibroblasts
( Ulirey, 1982) have suggested that glucose down-regulates Its
own transport through certain intermediate(s) of its metabolism.
Gay and Amos (1983) further proposed that a glucose metabolite,
5-phosphoribosyl pyrophosphate (PRPP) may be the suspected
transport Inactivator. In this thesis, the PRPP levels and
glucose transport capacity of EAT cells u-nder a variety of
experimental conditions have been examined. An inverse
relationship between intracellular PRPP levels and glucose
transport activities is hold when EAT cells are treated with
different concentration of glucose, 2, 4-dinitrophenol,
methotrexate (MTX) or hypoxanthine. However, inconsistent
results were also obtained. Hyperthermia and recombinant human
TNF (rhTNF) decreased the rate of glucose transport without
significant effect on PRPP level in EAT cells. Furthermore,
guanine and guanosine can deplete the intracellular PRPP but
cause a suppression of glucose uptake in EAT cells. so, the
exact role of PRPP in the regulation of glucose transport is
still speculated and awaits for further elucidation.
our results showed that certain kinds of cancer treatment
such as hyperthermia, methotrexate or tumour necrosis factor
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containing serum (TNS) and rhTNF can effectively arrest the
tumour growth, inhibit glucose uptake and reduce the number of
glucose carriers in EAT cells in vitro. Since glucose is a
primary energy source for most tumour cells, suppression of
glucose transport by these treatments might decrease the energy
supply to the cancer cells and contribute towards death of
tumour.
The potential of using hyperthermia to potentiate the
therapeutic effect of anti-cancer agents has been noted( for
review, see Bertino, 1984). Our results also indicated that the
efficacy of anti-tumour agents such as MTX, 5-Eluorouracil,
cytarabine and TNF could be enhanced by hyperthermia. It is of
interest to further elucidate the mechanism of enhancement which
may then act as a useful guide for the clinical trail in
thermochemotherapy. The present study has revealed that
hyperthermia exert an additional effect on suppression of glucose
transport in MTX-treated and rhTNF-treated EAT cells. The
combined effect of hyperthermia with other anti-cancer agents on
glucose transport system is worth studying. Recently, it has
been reported that some chemicals such as certain CAMP
stimulating agents, sodium butyrate( Kim et al., 1984 Rama and
Prasad, 1986) or vitamin E.( Rama and Prasad, 1984), when
treated in non-toxic doses, can enhance the thermal sensitivity
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Glucose-free culture medium was prepared according to the
formula of RPMI 1640 (Gibco) but omitting glucose. The


























































































Triton X- toluene Scintillant
Constituent Quantity
P P 0 12.00 g
POPOP 1.20 g
2.00 1Toluene
1.00 1Triton X-100


